Skip to main content
Annals of Medicine logoLink to Annals of Medicine
. 2024 May 10;56(1):2328521. doi: 10.1080/07853890.2024.2328521

Global burden of liver cirrhosis 1990–2019 and 20 years forecast: results from the global burden of disease study 2019

Yikai Wang 1, Muqi Wang 1, Chenrui Liu 1, Miao Hao 1, Wenjun Wang 1, Yaping Li 1, Juanjuan Shi 1, Xiaoli Jia 1, Xin Zhang 1, Shuangsuo Dang 1,
PMCID: PMC11089929  PMID: 38727511

Abstract

Background

Cirrhosis is a disease that imposes a heavy burden worldwide, but its incidence varies widely by region. Therefore, we analysed data on the incidence and mortality of cirrhosis in 204 countries and territories from 1990–2019 and projected the disease development from 2019–2039.

Methods

Data on the incidence and mortality of liver cirrhosis from 1990 to 2019 were acquired from the public Global Burden of Disease (GBD) study. In addition, the average annual percentage change (AAPC) and estimated annual percentage change (EAPC) of the age-standardized rate (ASR) of cirrhosis in different regions were calculated. The estimates of risk factor exposure were summarized, and the proportion of causes and risk factors of liver cirrhosis and their relationship with the human development index (HDI) and socio–demographic index (SDI) were analysed. Trends in the incidence of cirrhosis in 2019–2039 were predicted using Nordpred and BAPC models.

Results

Globally, the ASR of cirrhosis incidence decreased by 0.05% per year from 25.7/100,000 in 1990 to 25.3/100,000 in 2019. The mortality risk associated with cirrhosis is notably lower in females than in males (13 per 100,000 vs 25 per 100,000). The leading cause of cirrhosis shifted from hepatitis B to C. Globally, alcohol use increased by 14%. In line, alcohol use contributed to 49.3% of disability-adjusted life years (DALYs) and 48.4% of global deaths from liver cirrhosis. Countries with a low ASR in 1990 experienced a faster increase in cirrhosis, whereas in 2019, the opposite was observed. In countries with high SDI, the ASR of cirrhosis is generally lower. Finally, projections indicate that the number and incidence of cirrhosis will persistently rise from 2019–2039.

Conclusions

Cirrhosis poses an increasing health burden. Given the changing etiology, there is an imperative to strengthen the prevention of hepatitis C and alcohol consumption, to achieve early reduce the incidence of cirrhosis.

Keywords: Cirrhosis, disease burden, liver disease, prediction, trend

KEY MESSAGES

  • This study is an updated assessment of liver cirrhosis prevalence trends in 204 countries worldwide and the first to project trends over the next 20 years.

  • The disease burden of cirrhosis is still increasing, and despite the decline in ASR, the number and prevalence of cirrhosis will continue to increase over the next two decades after 2019.

  • It is alarming that the global surge in alcohol use is accompanied by an increase in DALYs and deaths due to liver cirrhosis.

  • Liver cirrhosis remains a noteworthy public health event, and our study can further guide the development of national healthcare policies and the implementation of related interventions.

1. Introduction

Liver cirrhosis is an integral part of the development of chronic liver disease. It is characterized by diffuse liver fibrosis due to prolonged injury and inflammation, regrowth of small nodules surrounded by fibrotic septa and intrahepatic vascular shunting [1]. As cirrhosis progresses, it impairs important liver functions, including protein synthesis, detoxification, and the regulation of related metabolic processes and increases the risk of liver cancer. The main causes of liver cirrhosis include long–term alcohol abuse, viral hepatitis infection (especially hepatitis B and C), non–alcoholic fatty liver disease (NAFLD) and autoimmune diseases [2,3].

The incidence of liver cirrhosis varies widely in various regions of the world. Globally, cirrhosis causes approximately two million deaths each year [4]. In the United States, the prevalence of cirrhosis is estimated at 0.15% [5], resulting in more than 25,000 deaths in 1998 [6]. In China, the incidence of liver cirrhosis per thousand people increased by 73.7%, from 6833.3 in 1990 to 11869.6 in 2016 [7]. Due to the great differences in the level of economic development and population composition in different regions, the burden caused by liver cirrhosis also varies greatly. For the 1980–2010 global burden of disease study (GBD), the study of liver cirrhosis by Mokdad et al., the number of deaths from liver cirrhosis increased from 676,000 in 1980 (95% uncertainty interval (UI): 452,863 to 1,004,530) in 2010 1,029,042 (95% UI: 670,216 to 1,554,530); but the age–standardized death rate decreased by 22% [4]. The same changes were also shown in a 2017 GBD study. The study analysed cirrhosis data from 195 countries and found that the number of deaths increased from 899 000 (95% UI: 829 000–948 000) in 1990 to 1.32 million (95% UI: 1.27–1.45) in 2017; the age–standardized death rate decreased from 21.0 (19.2–22.3) per 100,000 in 1990 to 16.5 (15.8–18.1) per 100,000 in 2017 [8]. Both of these previous studies showed the same trend, with an increase in cirrhosis deaths and a gradual decline in age–standardized death rates.

Therefore, based on the latest GBD data in 2019, this study analyses and evaluates the disease burden of liver cirrhosis in 204 countries and regions around the world from 1990 to 2019, and predicts the changing trend of its health burden in the next 20 years, to provide a reference for decision–makers.

2. Methods

2.1. Data sources

The data used in this article comes from GBD 2019, which systematically assessed 369 diseases and 87 risk factors in 204 countries and territories [9]. We extracted data on incidence, deaths, age–standardized incidence and deaths, summary exposure value, and risk factors for morbidity associated with cirrhosis by country and territory from 1990 to 2019 from the Global Health Data Exchange Query Tool (http://ghdx.healthdata.org/gbd–results–tool) [9]. In terms of age selection, in addition to selecting ‘all ages’ and ‘age-standardized’ for analysis, we also selected the following age groups: ‘<1 year’, ‘1–4 years’, ‘5–9 years’, ‘10–14 years’, ‘15–19 years’, ‘20–24 years’, ‘25–29 years’, ‘30–34 years’, ‘35–39 years’, ‘40–44 years’, ‘45–49 years’, ‘50–54 years’, ‘55–59 years’, ‘60–64 years’, ‘65–69 years’, ‘70–74 years’, ‘75–79 years’, ‘80–84 years’, ‘85–89 years’, ‘90–94 years’, ‘95+ years’. Further, we retrieved and analysed the composition ratio of liver cirrhosis cases in five aetiological groups (hepatitis B, hepatitis C, NAFLD, alcohol use, and other causes) and studied two risk factors (alcohol use) and (drug use) rate of liver cirrhosis.

We also collected national–level Human Development Index (HDI) data (https://hdr.undp.org/data–center/human–development–index#/indicies/HDI) from the World Bank to explore the relationship between HDI and cirrhosis. In addition, we obtained the global population forecast information for 2017–2100 in the GBD database (https://ghdx.healthdata.org/record/ihme–data/global–population –forecasts–2017–2100), to further predict the future development trend of liver cirrhosis.

2.2. Statistical analysis

Because the included data had different age groups and changed over time, we assessed them using age–standardized rates (ASR). The calculation of ASR is based on the world standard population in the GBD database, and heterogeneity is estimated using a 95% uncertainty interval (UI) [10]. Further, we use estimated annual percentage change (EAPC) and average annual percentage change (AAPC) to assess the trend of ASR over time. The regression line is fitted to the natural logarithm of the ratio, y = α + βx + e, where y = ln (ASR) and x = calendar year. EAPC is calculated as 100 × [exp (β)-1], and its 95% confidence interval (CI) can also be obtained from the linear regression model [11]. In addition, we used Joinpoint Regression Program version 4.9.1.0 (Statistical Research and Applications Branch, National Cancer Institute) to calculate AAPC, AAPC = {exp (Σwibi/Σwi) − 1} * 100, where bi is the slope coefficient for each segment in the desired year range, and wi is the length of each segment in the year range. Next, EAPCs for morbidity and mortality were clustered using hierarchical cluster analysis, and countries with similar trends in EAPCs were identified. In addition, the relationships between EAPCs, ASRs (1990 and 2019), and HDI (2022) were determined for each country. To clarify the relationship between socioeconomic development and the occurrence of liver cirrhosis, we included the GBD database (https://ghdx.healthdata.org/record/ihme–data/gbd–2019–socio–demographic–index–sdi–1950–2019) of socio–demographic index (SDI) data from 1950–2019. The national economic development level is divided into low, medium–low, medium, high–medium, and high SDI according to the quintiles of the SDI value, and the value ranges from 0 to 1.

To predict the incidence of future cirrhosis, we used the Nordpred package in the R software to analyse the number and incidence of cirrhosis in different age groups from 2019 to 2039 and calculated ASR by gender. To verify the reliability of the predicted results, we used the BAPC and INLA packages in R software for analysis. Statistics of all data in this study were performed using R software (version 4.2.1) and p < 0.05 was considered statistically significant.

3. Results

3.1. Global disease burden of cirrhosis

First, we analyzed the age–standardized incidence rate (ASIR) of each country and territory in 2019. Moldova (80 per 100000, 95% UI: 71.7 − 86.3) has the highest ASIR, followed by Mongolia (79.6 per 100000, 95% UI: 66.4 − 94.2) and Egypt (78.7 per 100000, 95% UI: 62.3–99). Papua New Guinea (6.1 per 100000, 95% UI: 4.9 − 7.2), by comparison, has the lowest ASIR among countries and territories, followed by Cook Islands (6.1 per 100000, 95% UI: 5 − 7.1) and Jamaica (8.5 per 100000, 95% UI: 7.3 − 9.8) (Figure 1(A) and Table 1). Further, we analysed the changes in the number of cases of cirrhosis in each country and territory from 1990 to 2019. As shown in Figure 1(B), the number of cases in the United Arab Emirates increased by 820%, from 219.5 in 1990 to 2019.1 in 2019 (Figure 1(B) and Table 1). Meanwhile, the number of cases in the Republic of Korea dropped 43.9%, from 30,126.5 in 1990 to 16,886.5 in 2019 (Figure 1(B) and Table 1). To better assess the changes of ASIR in liver cirrhosis, we performed an EAPC analysis. The results show that Kazakhstan has the fastest ASIR growth with an average annual growth rate of 4.3% (95% CI: 4.1 − 4.5), while the Republic of Korea has the fastest ASIR decline with an average annual growth rate of 3.9% (95% CI: −4.1 to −3.7) (Figure 1(C) and Table 1). The results of the AAPC analysis are consistent. Kazakhstan is the fastest growing ASIR with an average annual growth rate of 3.632% (95% CI: 3.505 − 3.759), while the Republic of Korea is the fastest declining ASIR with an average annual growth rate of 3.345% (95% CI: −3.548 to −3.14) (Table 2).

Figure 1.

Figure 1.

Incidence of cirrhosis in 204 countries and regions worldwide burden of disease: A. ASR for the incidence of cirrhosis in 2019; B. Changes in the cases of cirrhosis from 1990 to 2019; C. EAPC analysis of cirrhosis ASR from 1990 to 2019. ASIR, age-standardized rate; EAPC, estimated annual percent change. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

Table 1.

ASIR, change in case numbers and EAPC for cirrhosis in different countries.

Country ASIR per 100,000
NO. (95% UI)
Cases change
EAPC
NO. (95%CI)
Case_1990 Case_2019 Cases change
(%)
Afghanistan 22.5 (17.7–27.9) 1883.6 6354.9 237.4 0.4 (0.3–0.5)
Albania 21.9 (19.1–24.6) 710.8 640.7 −9.9 −0.5 (−0.7 to −0.4)
Algeria 19.2 (15.8–23.1) 3379.8 7823.4 131.5 −0.2 (−0.3−0)
American Samoa 13.8 (11.6–16.1) 6.3 7.3 16.0 −0.4 (−0.4 to −0.3)
Andorra 20.2 (17.5–22.7) 14.7 22.3 51.9 −0.6 (−0.6 to −0.5)
Angola 23.5 (18.6–29.1) 1629.1 6052.1 271.5 0.9 (0.7−1.1)
Argentina 27.3 (23.9–30.8) 6741.4 13006.4 92.9 0.8 (0.7−0.8)
Armenia 44.3 (38.5–50.7) 660.3 1595.6 141.6 3.3 (3.1−3.5)
Australia 10.5 (8.9–12.1) 2073.0 2876.7 38.8 −0.3 (−0.4 to −0.3)
Austria 29.3 (26.7–31.7) 3449.1 2913.7 −15.5 −1.3 (−1.5 to −1.2)
Azerbaijan 51.5 (43.2–60.5) 2210.3 6436.9 191.2 1.5 (1.4−1.7)
Bahamas 18.8 (16.1–21.5) 50.8 82.1 61.6 −0.9 (−1 to −0.8)
Bahrain 28 (23.5–33.3) 89.4 480.2 437.4 0.3 (0.1−0.4)
Bangladesh 18.6 (15.5–21.6) 18413.6 28892.6 56.9 0.4 (0.2–0.5)
Barbados 14.2 (12.2–16.2) 36.6 47.0 28.2 −0.5 (–0.6 to –0.5)
Belarus 26.5 (23.5–29.3) 1372.9 2576.5 87.7 3.2 (2.7–3.7)
Belgium 23.8 (21.2–26.5) 2602.2 2920.3 12.2 −0.2 (–0.3 to –0.1)
Belize 24.6 (20.9–28.4) 26.7 97.2 264.4 0.4 (0.3–0.6)
Benin 26 (21.2–31.2) 951.0 2722.1 186.2 0.1 (–0.1–0.3)
Bermuda 13.9 (11.9–15.8) 11.4 10.6 −7.8 −1 (–1.1 to –0.9)
Bhutan 25.9 (21–31.2) 125.9 200.9 59.6 0.6 (0.6–0.7)
Bolivia 31.6 (26.4–38.3) 1220.9 3422.0 180.3 0.8 (0.7–0.9)
Bosnia and Herzegovina 21.2 (18.7–23.5) 1322.5 802.1 −39.3 −1 (–1.1 to –1)
Botswana 24.1 (19.5–28.9) 269.9 589.5 118.4 0.2 (0–0.3)
Brazil 19.9 (14.4–25.8) 35430.2 49123.8 38.6 −1.3 (–1.4 to –1.2)
Bulgaria 31.7 (28.8–34.6) 2651.3 2425.5 −8.5 0.4 (0.4–0.4)
Burkina Faso 22.5 (17.1–28.6) 1778.9 4254.8 139.2 −0.1 (–0.2–0.1)
Burundi 22 (16.8–28.2) 882.1 2004.6 127.3 0.4 (0.3–0.5)
Cambodia 52.1 (42.3–63.3) 3738.9 8387.8 124.3 0.2 (0.2–0.2)
Cameroon 25.6 (20.6–31.4) 2237.8 6303.9 181.7 −0.1 (–0.2–0)
Canada 19.4 (17.2–21.7) 6170.2 7771.6 26.0 −0.2 (–0.3 to –0.2)
Central African Republic 28.6 (20.9–37) 667.5 1359.6 103.7 0 (0–0.1)
Chad 28 (22.5–33.8) 1360.7 3690.3 171.2 −0.1 (–0.1–0)
Chile 40.4 (36–44.7) 4865.2 8553.4 75.8 −0.3 (–0.4 to–0.1)
China 22.5 (17.6–27.6) 310191.3 409693.6 32.1 −0.5 (–0.6 to–0.4)
Colombia 15.3 (13.5–17.3) 4961.9 7858.1 58.4 −0.8 (–0.8 to –0.7)
Comoros 24.6 (19–30.5) 84.2 165.0 96.0 0.3 (0.2–0.3)
Cook Islands 6.1 (5–7.1) 1.0 1.1 5.2 0 (0–0.1)
Costa Rica 30.4 (27–34.3) 762.1 1575.2 106.7 0 (0–0)
Côte d’Ivoire 26.6 (21.1–32) 2504.0 6084.0 143.0 0.1 (–0.1–0.3)
Croatia 32.5 (29.7–35.3) 2404.6 1532.5 −36.3 −1.2 (–1.3 to –1.1)
Cuba 17 (15–19) 1508.2 2228.3 47.7 0.6 (0.5–0.6)
Cyprus 18.4 (15.8–21.1) 161.4 287.7 78.3 −0.6 (–0.7 to –0.5)
Czech Republic 22.1 (19.9–24.4) 2715.2 2670.6 −1.6 −0.2 (–0.3 to –0.1)
Democratic Republic of the Congo 28.7 (22.8–35.3) 7896.2 21836.7 176.5 0.6 (0.5–0.6)
Denmark 21.4 (18.9–23.7) 1015.3 1242.0 22.3 0.6 (0.2–1)
Djibouti 22.9 (18.5–27.7) 92.2 263.6 186.0 −0.3 (–0.4 to –0.2)
Dominica 15 (12.6–17.4) 10.2 10.9 7.3 −0.7 (–0.8 to –0.6)
Dominican Republic 30 (24.8–35.4) 1417.6 3263.1 130.2 0.4 (0.3–0.5)
Ecuador 38.5 (34.9–42.3) 1689.3 6405.9 279.2 1.9 (1.6–2.1)
Egypt 78.7 (62.3–99) 24559.5 65387.7 166.2 0.7 (0.7–0.8)
El Salvador 36.3 (31.3–41.3) 1372.8 2188.5 59.4 0.2 (0.1–0.3)
Equatorial Guinea 24 (19.3–29.4) 92.2 282.1 205.8 −0.2 (–0.3 to –0.1)
Eritrea 29.1 (22.8–35.6) 539.9 1631.3 202.2 0.7 (0.6–0.8)
Estonia 22 (19.5–24.5) 209.3 277.6 32.6 1.8 (1.4–2.2)
Ethiopia 28.1 (17.5–39.8) 10269.5 22299.5 117.1 0.2 (0.1–0.3)
Fiji 10.2 (8.4–12) 79.7 96.2 20.6 −0.4 (–0.5 to –0.4)
Finland 21.8 (19.7–23.7) 837.2 1124.6 34.3 1.7 (1.3–2)
France 21.2 (18.8–23.4) 18974.9 14331.2 −24.5 −1.6 (–1.6 to –1.5)
Gabon 17 (13.6–20.8) 144.2 280.9 94.8 0 (–0.1–0.1)
Gambia 26.7 (21.7–32) 208.8 492.7 136.0 −0.1 (–0.1–0)
Georgia 31.6 (27.3–35.5) 1833.3 1247.7 −31.9 −0.2 (–0.3–0)
Germany 28.8 (26.2–31.4) 29343.9 25398.9 −13.4 −0.6 (–0.8 to –0.5)
Ghana 21.9 (17.7–26.4) 3065.5 6227.0 103.1 −0.6 (–0.7 to –0.5)
Greece 15.8 (13.7–17.6) 2627.2 1803.4 −31.4 −1.6 (–1.6 to–1.5)
Greenland 16 (13.8–17.9) 9.9 9.1 −7.8 0.2 (0.2–0.3)
Grenada 21.3 (18–24.7) 13.2 24.3 84.0 −0.2 (–0.2 to –0.1)
Guam 19.2 (16.2–22.3) 30.7 31.8 3.5 −0.9 (–1 to –0.8)
Guatemala 52 (45.2–58.9) 2898.9 8092.3 179.2 0.5 (0.4–0.5)
Guinea 22.5 (18.1–27) 1262.3 2419.0 91.6 −0.4 (–0.6 to –0.3)
Guinea–Bissau 25.8 (20.2–31.5) 238.9 429.9 80.0 −0.5 (–0.6 to –0.5)
Guyana 34 (28.2–39.4) 214.7 262.8 22.4 0 (–0.1–0.1)
Haiti 25.3 (20.3–30.8) 1084.3 2778.6 156.3 0.6 (0.5–0.6)
Honduras 36.6 (30.1–42.9) 1361.8 3080.4 126.2 −0.4 (–0.5 to –0.3)
Hungary 32 (29–35) 6257.7 3701.0 −40.9 −2.4 (–2.6 to –2.1)
Iceland 9.6 (8.4–10.8) 23.3 33.5 44.2 0.3 (0.3–0.4)
India 23.2 (16.5–30.6) 138576.4 326903.9 135.9 1.5 (1.4–1.6)
Indonesia 23.2 (14.5–32.3) 47107.3 64125.6 36.1 −1.3 (–1.5 to –1)
Iran 16.6 (12.1–21.7) 6502.4 14346.0 120.6 0.3 (0.2–0.5)
Iraq 18.3 (15.5–21.1) 2161.7 6593.1 205.0 0.5 (0.3–0.6)
Ireland 15.4 (13.6–17.2) 391.5 826.0 111.0 1.1 (0.9–1.3)
Israel 17.3 (14.9–19.6) 826.6 1588.8 92.2 −0.6 (–0.7 to –0.4)
Italy 32.7 (26.6–39.1) 30032.3 24482.7 −18.5 −1.4 (–1.5 to –1.2)
Jamaica 8.5 (7.3–9.8) 196.2 246.2 25.4 −0.9 (–1 to –0.8)
Japan 25.9 (21–31.3) 46734.0 33114.8 −29.1 −0.3 (–0.5 to –0.2)
Jordan 17.4 (14.8–20.4) 424.5 1763.5 315.4 0.1 (0.1–0.2)
Kazakhstan 63.3 (55.6–71.2) 3469.9 12698.3 266.0 4.3 (4.1–4.5)
Kenya 36.5 (22.2–52.3) 5233.6 14848.4 183.7 −0.1 (–0.2–0)
Kiribati 17.4 (13.3–21.8) 13.6 20.0 47.1 −0.6 (–0.8 to –0.5)
Kuwait 15.2 (13–17.4) 174.8 755.7 332.2 1.3 (1.1–1.4)
Kyrgyzstan 48.9 (43.2–55.4) 1311.3 3182.6 142.7 1.3 (1–1.5)
Laos 24.9 (20.2–29.9) 739.5 1683.1 127.6 0.3 (0.2–0.4)
Latvia 20 (17.9–22.3) 360.5 353.7 −1.9 1.8 (1.4–2.2)
Lebanon 21.3 (17.8–25.3) 469.6 1109.6 136.3 1 (0.9–1.1)
Lesotho 20.6 (15.9–25.8) 343.4 431.8 25.7 −0.6 (–0.8 to –0.5)
Liberia 21.3 (17–26) 315.4 897.2 184.5 0.4 (0.2–0.5)
Libya 17.1 (14.3–20.4) 548.0 1142.4 108.4 −0.2 (–0.3 to –0.1)
Lithuania 27.8 (25–30.6) 529.6 677.8 28.0 2.8 (2.3–3.4)
Luxembourg 26.4 (23.2–29.3) 157.9 196.1 24.2 −1.4 (–1.6 to –1.1)
Madagascar 25.3 (20.4–30.4) 1900.9 5724.3 201.1 0.9 (0.7–1.2)
Malawi 27.7 (21.8–34.6) 2095.8 3866.0 84.5 −0.2 (–0.3 to –0.2)
Malaysia 21.1 (17.9–24.6) 2622.6 6861.1 161.6 0.3 (0.2–0.5)
Maldives 13.8 (11.6–16.1) 19.9 76.1 282.4 0.3 (0.1–0.5)
Mali 28 (21.8–34.5) 1683.6 5093.2 202.5 1.1 (1–1.3)
Malta 13.5 (12–15) 66.9 61.1 −8.7 −0.6 (–0.7 to –0.5)
Marshall Islands 16.8 (13.3–20.3) 6.9 9.8 41.4 −0.6 (–0.7 to –0.5)
Mauritania 23.8 (19.4–28.9) 432.6 826.0 90.9 −0.4 (–0.5 to –0.3)
Mauritius 17.8 (15.4–20.3) 315.0 252.6 −19.8 −2.1 (–2.3 to –1.8)
Mexico 55.4 (41.4–69.9) 39192.5 73785.2 88.3 0 (–0.1–0)
Moldova 80 (71.7–86.3) 4338.6 3504.2 −19.2 −0.6 (–0.9 to –0.3)
Monaco 23.8 (20.7–26.6) 7.4 8.6 16.9 0.3 (0.2–0.4)
Mongolia 79.6 (66.4–94.2) 816.8 2950.8 261.2 1.9 (1.7–2.1)
Montenegro 10.6 (9.1–12) 68.0 66.6 −2.0 0 (–0.1–0)
Morocco 18.8 (15.6–22.6) 3296.2 6917.5 109.9 0.3 (0.1–0.4)
Mozambique 17.7 (13.8–22.4) 1754.9 4206.3 139.7 0.3 (0.1–0.4)
Myanmar 34.3 (28.5–40) 12459.9 19740.1 58.4 −0.1 (–0.2 to –0.1)
Namibia 21.9 (17.7–26.4) 236.4 492.6 108.4 0 (–0.1–0.1)
Nauru 17.4 (13.9–20.9) 1.5 1.8 16.8 0.1 (0–0.1)
Nepal 24.3 (20.2–28.9) 3745.8 7106.8 89.7 0.5 (0.5–0.6)
Netherlands 15.3 (13.3–17.3) 2751.7 2786.8 1.3 −0.4 (–0.5 to –0.2)
New Zealand 8.7 (6.8–10.8) 318.9 438.2 37.4 −0.1 (–0.2 to –0.1)
Nicaragua 37.9 (32.9–42.7) 838.8 2395.9 185.6 1 (0.8–1.2)
Niger 30.8 (24–38.4) 1939.0 5636.0 190.7 0.1 (0.1–0.2)
Nigeria 27.1 (17.8–37.2) 17729.5 47955.3 170.5 0.5 (0.4–0.6)
Niue 14.7 (12.1–17.3) 0.3 0.2 −16.1 −0.1 (–0.2–0)
Democratic People’s Republic of Korea 20.3 (16.3–24.1) 5236.6 6457.5 23.3 −0.8 (–1 to –0.7)
Northern Mariana Islands 29.8 (24.5–35.5) 17.4 14.2 −18.5 −0.8 (–0.9 to –0.6)
Norway 15.1 (11.8–18.7) 701.0 835.0 19.1 0.7 (0.4–0.9)
Oman 29.3 (24.2–35.2) 317.8 1036.5 226.1 0.5 (0.4–0.6)
Pakistan 25.1 (17–33.9) 24805.7 50880.2 105.1 0 (0–0)
Palau 17 (13.9–20.3) 2.4 3.6 50.5 0.1 (0–0.2)
Palestine 21.6 (18.3–25.5) 272.4 821.2 201.4 0.4 (0.1–0.7)
Panama 22.3 (19.4–24.9) 425.7 950.0 123.2 0.2 (0–0.3)
Papua New Guinea 6.1 (4.9–7.2) 236.5 617.3 161.0 −0.1 (–0.1–0)
Paraguay 15.7 (13.3–18.2) 471.0 1062.9 125.6 0.1 (0–0.2)
Peru 29.4 (25.3–33.9) 4297.5 10145.3 136.1 0.7 (0.5–0.9)
Philippines 19.6 (13.6–25.9) 8344.5 21019.1 151.9 0.8 (0.7–1)
Poland 21.1 (15.7–27.1) 9550.3 8644.4 −9.5 −0.4 (–0.7 to –0.1)
Portugal 18.5 (16.3–20.5) 3889.6 2238.9 −42.4 −2.8 (–3 to –2.6)
Puerto Rico 24.4 (20.9–27.4) 1216.4 948.1 −22.1 −1.6 (–1.7 to –1.4)
Qatar 39.4 (32.4–47.9) 102.4 934.2 812.8 1 (0.8–1.2)
Republic of Congo 20.7 (16.6–25.2) 426.4 1022.1 139.7 0.1 (0–0.2)
Romania 51.2 (46.9–55.2) 11829.8 12134.7 2.6 0.1 (–0.1–0.3)
Russia 29.9 (21.6–39.4) 28493.8 45082.2 58.2 2 (1.8–2.3)
Rwanda 32.4 (25.6–39.4) 1688.6 3382.7 100.3 0.3 (0.2–0.4)
Saint Lucia 19.2 (16.4–22) 23.2 39.8 71.4 −0.8 (–0.9 to –0.6)
Samoa 17.5 (14.5–20.9) 23.1 33.7 46.0 −0.2 (–0.3 to –0.1)
San Marino 33.1 (29–36.9) 9.0 12.1 34.6 −0.4 (–0.5 to –0.4)
Sao Tome and Principe 33.5 (27.1–40.3) 38.0 62.9 65.7 −0.5 (–0.5 to –0.4)
Saudi Arabia 32.5 (26.9–38.5) 2998.5 10224.5 241.0 0.3 (0.2–0.3)
Senegal 27.4 (21.9–33) 1672.4 3594.2 114.9 0 (0–0.1)
Serbia 17.7 (15.8–19.6) 1975.1 1640.8 −16.9 −0.3 (–0.4 to –0.2)
Seychelles 28.3 (23.7–32.8) 17.3 34.7 100.3 −0.1 (–0.2 to –0.1)
Sierra Leone 24.4 (19.6–29.6) 595.0 1747.1 193.6 1.3 (1.1–1.5)
Singapore 11.2 (9.8–12.6) 560.6 747.6 33.3 −1.6 (–1.8 to –1.4)
Slovakia 32.6 (29–36.1) 2042.8 2056.9 0.7 −0.3 (–0.4 to –0.2)
Slovenia 31.1 (28–34) 992.6 740.0 −25.5 −1.5 (–1.6 to –1.3)
Solomon Islands 20.6 (16.7–24.8) 63.9 132.8 107.9 −0.4 (–0.5 to –0.3)
Somalia 29.7 (21.4–39.1) 1548.3 4398.1 184.1 0.1 (0–0.2)
South Africa 13.8 (9.6–18.3) 6346.7 7807.5 23.0 −1.3 (–1.4 to –1.2)
Republic of Korea 25.5 (22.5–28.9) 30126.5 16886.5 −43.9 −3.9 (–4.1 to –3.7)
South Sudan 23 (17.2–29.4) 953.9 1705.5 78.8 0.3 (0.2–0.3)
Spain 23.3 (20.6–25.9) 15287.3 13480.1 −11.8 −2 (–2.1 to –1.9)
Sri Lanka 23.3 (19.7–26.8) 4156.9 5600.8 34.7 −0.7 (–0.9 to –0.5)
Sudan 15.8 (12.4–19.8) 1954.9 4800.6 145.6 0.6 (0.3–0.9)
Suriname 23.7 (20–27.6) 74.3 151.2 103.5 0 (–0.1–0)
Sweden 15.3 (12–19) 1238.3 1605.4 29.6 0.5 (0.4–0.7)
Switzerland 17.5 (15.5–19.6) 1468.5 1747.1 19.0 −0.3 (–0.5 to –0.2)
Syria 24 (20.3–28.3) 1902.8 3557.6 87.0 0.7 (0.6–0.7)
Taiwan 26.6 (23–29.9) 9075.2 8204.8 −9.6 −2.1 (–2.4 to –1.9)
Tajikistan 53.8 (45.9–62.3) 1251.9 4716.5 276.7 2.4 (2.3–2.5)
Tanzania 22.2 (17.6–27.5) 4065.5 10011.0 146.2 0.1 (0–0.2)
Thailand 24.2 (20.7–27.9) 12333.2 20264.9 64.3 0.4 (0.3–0.5)
Timor-Leste 26.4 (20.9–32) 140.4 275.5 96.2 0.7 (0.7–0.8)
Togo 26.6 (21–32.7) 736.9 1880.5 155.2 0.3 (0.2–0.4)
Tokelau 12.4 (10.2–14.6) 0.2 0.2 −0.8 −0.1 (–0.1–0)
Tonga 20.1 (16.5–23.9) 15.9 18.5 16.6 −0.4 (–0.5 to –0.3)
Tunisia 20.7 (17.3–24.6) 1153.7 2680.9 132.4 0.6 (0.5–0.7)
Turkey 18.7 (16.2–21.5) 6651.2 16568.3 149.1 1.5 (1.4–1.6)
Turkmenistan 53.3 (46.7–60.2) 1188.5 2843.1 139.2 1.1 (1–1.2)
Tuvalu 14.3 (11.7–16.9) 1.2 1.6 40.5 0.2 (0.1–0.2)
Uganda 23.4 (18.2–29.6) 2791.9 6934.0 148.4 0 (–0.1–0)
UK 23.9 (19.8–28.4) 8657.4 16129.7 86.3 1.5 (1.2–1.7)
Ukraine 33.7 (22.6–47.3) 10702.4 14401.2 34.6 2 (1.8–2.3)
United Arab Emirates 18 (14.9–21.6) 219.5 2019.1 820.0 0.1 (0–0.2)
Uruguay 17.1 (14.7–19.3) 580.3 637.3 9.8 −0.6 (–0.7 to –0.5)
USA 26.3 (21.8–31.2) 65860.2 90854.4 38.0 0.2 (0.1–0.3)
Uzbekistan 65.2 (57.6–72.9) 6750.2 22488.6 233.2 1.6 (1.3–1.9)
Vanuatu 23.1 (18.1–28.1) 33.4 61.8 84.9 −0.6 (–0.6 to –0.5)
Venezuela 20.1 (17.5–22.8) 3887.7 6248.9 60.7 −0.9 (–0.9 to –0.8)
Vietnam 29.3 (25.1–33.7) 13537.6 32979.7 143.6 0.3 (0–0.5)
Yemen 20.2 (16.5–24.4) 1737.0 4660.3 168.3 0.4 (0.2–0.5)
Zambia 32.2 (26–39) 1839.1 4513.0 145.4 0 (–0.1–0)
Zimbabwe 20.1 (15.8–25) 1753.3 2657.4 51.6 −0.4 (–0.7–0)

ASIR: age–standardized incidence rate; CI: confidence interval; EAPC: estimated annual percentage change; UI: uncertainty interval.

Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

Table 2.

Incidence rate and age–standardized incidence of cirrhosis in various countries of the world from 1990 to 2019 and temporal trends from 1990 to 2019.

Country 1990
2019
1990–2019
Incident rate per 100,000
NO. (95% UI)
ASR per 100,000
NO. (95% UI)
Incident rate per 100,000
NO. (95% UI)
ASR per 100,000
NO. (95% UI)
AAPC
NO. (95%CI)
Afghanistan 1883.6 (1475.1–2358.6) 19.4 (14.4–24.9) 6354.9 (5272.2–7632.4) 22.5 (17.7–27.9) 0.556 (0.464–0.648)
Albania 710.8 (608.4–798.3) 25.2 (21.4–28.5) 640.7 (551.8–728.8) 21.9 (19.1–24.6) −0.488 (–0.508 to −0.468)
Algeria 3379.8 (2808.5–4044.2) 18.2 (14.6–22.6) 7823.4 (6480.6–9296.7) 19.2 (15.8–23.1) 0.175 (0.095–0.255)
American Samoa 6.3 (5.3–7.4) 14.5 (12–17.3) 7.3 (6.1–8.7) 13.8 (11.6–16.1) −0.213 (–0.32 to −0.105)
Andorra 14.7 (12.5–16.7) 23.1 (19.7–26.3) 22.3 (18.9–25.6) 20.2 (17.5–22.7) −0.483 (–0.524 to −0.443)
Angola 1629.1 (1312.1–1985) 18 (13.4–23) 6052.1 (5063.1–7307) 23.5 (18.6–29.1) 0.931 (0.887 to 0.975)
Antigua and Barbuda 9.6 (8.2–10.9) 18.2 (15.6–21.1) 19.2 (16.1–22.3) 18.1 (15.4–20.7) −0.027 (–0.056 to 0.002)
Argentina 6741.4 (5845.4–7740.9) 21.3 (18.5–24.6) 13006.4 (11347.4–14688.7) 27.3 (23.9–30.8) 0.857 (0.79–0.923)
Armenia 660.3 (577.4–755.4) 20.1 (17.5–22.9) 1595.6 (1345.3–1842.6) 44.3 (38.5–50.7) 2.757 (2.65–2.864)
Australia 2073 (1780.8–2348.8) 11.5 (9.9–13) 2876.7 (2420.9–3347.4) 10.5 (8.9–12.1) −0.338 (–0.432 to −0.243)
Austria 3449.1 (3147.9–3703.4) 41.8 (38.4–44.8) 2913.7 (2644.9–3163.1) 29.3 (26.7–31.7) −1.222 (–1.29 to −1.154)
Azerbaijan 2210.3 (1872.8–2623.4) 34.3 (29–40.3) 6436.9 (5306.1–7645.3) 51.5 (43.2–60.5) 1.427 (1.339–1.516)
Bahamas 50.8 (42.6–59.1) 22.2 (18.6–25.9) 82.1 (69.2–94.8) 18.8 (16.1–21.5) −0.58 (–0.628 to −0.532)
Bahrain 89.4 (75.2–103.9) 25.6 (21–31) 480.2 (388.5–563) 28 (23.5–33.3) 0.314 (0.252–0.377)
Bangladesh 18413.6 (15552.6–21213.3) 16.7 (13.7–19.9) 28892.6 (24167.3–33674) 18.6 (15.5–21.6) 0.359 (0.32–0.398)
Barbados 36.6 (31.2–42.2) 15.4 (13–17.8) 47 (40.3–54.4) 14.2 (12.2–16.2) −0.307 (–0.359 to −0.254)
Belarus 1372.9 (1180.1–1546.7) 13.2 (11.3–14.9) 2576.5 (2265.8–2869.9) 26.5 (23.5–29.3) 2.44 (2.301–2.58)
Belgium 2602.2 (2314.1–2836.9) 24.4 (21.8–26.7) 2920.3 (2567.5–3260.5) 23.8 (21.2–26.5) −0.104 (–0.149 to −0.058)
Belize 26.7 (22.9–30.8) 20.5 (17.1–24.1) 97.2 (82.7–112.2) 24.6 (20.9–28.4) 0.603 (0.558–0.647)
Benin 951 (785.7–1137.9) 23.6 (17.7–30) 2722.1 (2317.1–3176.3) 26 (21.2–31.2) 0.359 (0.253–0.465)
Bermuda 11.4 (9.7–13.1) 17 (14.4–19.5) 10.6 (8.9–12.3) 13.9 (11.9–15.8) −0.721 (–0.779 to −0.662)
Bhutan 125.9 (106.1–147.3) 22 (17.7–26.4) 200.9 (163–242.2) 25.9 (21–31.2) 0.569 (0.521– 0.617)
Bolivia (Plurinational State of) 1220.9 (1002.3–1464.5) 24.2 (19–29.7) 3422 (2898.3–4084.2) 31.6 (26.4–38.3) 0.943 (0.893 to 0.993)
Bosnia and Herzegovina 1322.5 (1162.6–1463.4) 27.7 (24.2–30.7) 802.1 (711.3–893.2) 21.2 (18.7–23.5) −0.934 (–0.967 to −0.901)
Botswana 269.9 (221.2–321.5) 24.5 (19–29.9) 589.5 (478.7–704.5) 24.1 (19.5–28.9) −0.02 (–0.133 to 0.093)
Brazil 35430.2 (25727.3–45963.4) 26.3 (18.6–34.4) 49123.8 (35225.2–64420.4) 19.9 (14.4–25.8) −0.946 (–1.107 to −0.785)
Brunei Darussalam 52.2 (45.1–59.6) 21.3 (18.4–23.8) 77.5 (67–86.8) 14.9 (13–16.7) −1.218 (–1.258 to −1.178)
Bulgaria 2651.3 (2384.6–2913.5) 28.5 (25.7–31.3) 2425.5 (2154.8–2669.1) 31.7 (28.8–34.6) 0.372 (0.341–0.403)
Burkina Faso 1778.9 (1509.9–2074.7) 22.1 (17.5–26.8) 4254.8 (3471.2–5182.5) 22.5 (17.1–28.6) 0.095 (0.032–0.157)
Burundi 882.1 (702.6–1082.6) 20.4 (15–26.4) 2004.6 (1626.6–2447.9) 22 (16.8–28.2) 0.257 (0.224–0.29)
Cabo Verde 64.7 (54.2–76.4) 21.3 (17.1–26) 135 (116–155.5) 23.7 (20–27.3) 0.366 (0.351–0.382)
Cambodia 3738.9 (3007.5–4509.9) 48 (37.4–59.3) 8387.8 (6893.1–10055.1) 52.1 (42.3–63.3) 0.235 (0.085–0.385)
Cameroon 2237.8 (1877.5–2661.1) 25.4 (20.1–31.1) 6303.9 (5271–7498.5) 25.6 (20.6–31.4) 0.035 (0.003– 0.067)
Canada 6170.2 (5519.5–6796.8) 20.4 (18.3–22.4) 7771.6 (6934.5–8737.3) 19.4 (17.2–21.7) −0.196 (–0.285 to −0.106)
Central African Republic 667.5 (506.3–832.9) 27.9 (20–36.6) 1359.6 (1053.5–1693.1) 28.6 (20.9–37) 0.076 (0.057–0.095)
Chad 1360.7 (1123.8–1624.1) 27.8 (20.9–34.6) 3690.3 (3118.7–4332.1) 28 (22.5–33.8) −0.003 (–0.052–0.047)
Chile 4865.2 (4226.1–5397) 39.7 (34.4–44.1) 8553.4 (7583.4–9515.8) 40.4 (36–44.7) 0.009 (–0.087–0.105)
China 310191.3 (224363.1–399447.1) 27 (19.1–35.2) 409693.6 (308245.1–514354.1) 22.5 (17.6–27.6) −0.621 (–0.721 to −0.522)
Colombia 4961.9 (4317.7–5590.8) 18.6 (16–21) 7858.1 (6925–8849) 15.3 (13.5–17.3) −0.666 (–0.702 to −0.629)
Comoros 84.2 (68–102.6) 22.8 (16.9–29) 165 (131.2–200.2) 24.6 (19–30.5) 0.284 (0.211–0.357)
Congo 426.4 (341.2–517.3) 19.9 (15–25.1) 1022.1 (832.9–1226.4) 20.7 (16.6–25.2) 0.138 (0.103–0.173)
Cook Islands 1 (0.8–1.2) 5.8 (4.7–6.9) 1.1 (0.9–1.3) 6.1 (5–7.1) 0.167 (0.14–0.195)
Costa Rica 762.1 (675.5–849.6) 30.1 (26.4–33.7) 1575.2 (1395.8–1773.1) 30.4 (27–34.3) 0.02 (–0.022– 0.062)
Côte d’Ivoire 2504 (2081.9–2970.6) 24.6 (19–30.3) 6084 (5035.3–7199.8) 26.6 (21.1–32) 0.307 (0.109–0.505)
Croatia 2404.6 (2190.7–2595) 44.8 (40.7–48.6) 1532.5 (1400.5–1663) 32.5 (29.7–35.3) −1.116 (–1.194 to −1.039)
Cuba 1508.2 (1327.2–1703.7) 14.2 (12.5–15.9) 2228.3 (1906.2–2568.3) 17 (15–19) 0.622 (0.597–0.648)
Cyprus 161.4 (135.1–187.5) 20.6 (17.3–23.9) 287.7 (244.9–331.6) 18.4 (15.8–21.1) −0.413 (–0.491 to −0.334)
Czechia 2715.2 (2411.8–3001.2) 24 (21.5–26.2) 2670.6 (2335.2–2975.4) 22.1 (19.9–24.4) −0.28 (–0.359 to −0.2)
Democratic People’s Republic of Korea 5236.6 (4246.4–6194.4) 25.2 (20.5–29.7) 6457.5 (5025.9–7874.2) 20.3 (16.3–24.1) −0.757 (–0.822 to −0.692)
Democratic Republic of the Congo 7896.2 (6443.1–9461.8) 23.9 (18.2–30.2) 21836.7 (18102–25885.2) 28.7 (22.8–35.3) 0.643 (0.605–0.68)
Denmark 1015.3 (913.5–1117.7) 18.3 (16.6–20.2) 1242 (1084.4–1385) 21.4 (18.9–23.7) 0.535 (0.343–0.727)
Djibouti 92.2 (76.3–109) 24.4 (18.8–30.2) 263.6 (215.7–314.7) 22.9 (18.5–27.7) −0.214 (–0.246 to −0.183)
Dominica 10.2 (8.7–11.6) 17.1 (14.3–19.8) 10.9 (9–12.9) 15 (12.6–17.4) −0.451 (–0.496 to −0.407)
Dominican Republic 1417.6 (1224.6–1631.1) 24.7 (20.9–29) 3263.1 (2705–3864.3) 30 (24.8–35.4) 0.697 (0.593–0.8)
Ecuador 1689.3 (1487.1–1918.6) 20.9 (18–23.9) 6405.9 (5833.2–7013.8) 38.5 (34.9–42.3) 2.089 (1.99–2.188)
Egypt 24559.5 (20171.4–29515) 61 (47.7–76.1) 65387.7 (52830.4–80948.6) 78.7 (62.3–99) 0.87 (0.806–0.934)
El Salvador 1372.8 (1201.2–1538.8) 33.4 (28.7–38) 2188.5 (1894.5–2491) 36.3 (31.3–41.3) 0.298 (0.26–0.336)
Equatorial Guinea 92.2 (71.2–114) 25.2 (18–33.1) 282.1 (234.8–336.6) 24 (19.3–29.4) −0.165 (–0.196 –to − 0.135)
Eritrea 539.9 (434–652.4) 23.2 (17.8–29) 1631.3 (1336.4–1952.2) 29.1 (22.8–35.6) 0.795 (0.757–0.833)
Estonia 209.3 (184.9–235.1) 13.4 (11.9–15.1) 277.6 (243.7–309.3) 22 (19.5–24.5) 1.707 (1.536–1.879)
Eswatini 129.9 (105.7–157.6) 18.9 (14.5–23.4) 204.2 (165.7–243.4) 18.4 (14.7–22.1) −0.113 (–0.206 to −0.019)
Ethiopia 10269.5 (7040.7–13905.9) 27 (15.2–40.5) 22299.5 (16351.8–29076.2) 28.1 (17.5–39.8) 0.154 (0.107–0.202)
Fiji 79.7 (65.9–93.9) 11 (8.9–13.1) 96.2 (79.3–113.1) 10.2 (8.4–12) −0.258 (–0.285 to −0.231)
Finland 837.2 (752.4–926) 14.8 (13.5–16.3) 1124.6 (1010.2–1228.8) 21.8 (19.7–23.7) 1.35 (1.285–1.415)
France 18974.9 (17062.9–20888) 31.1 (27.8–34.1) 14331.2 (12629.1–15952.4) 21.2 (18.8–23.4) −1.338 (–1.469 to −1.208)
Gabon 144.2 (116.5–174.1) 16.6 (12.6–20.9) 280.9 (230–339.4) 17 (13.6–20.8) 0.077 (0.058–0.095)
Gambia 208.8 (175.8–246.1) 26.4 (20.5–32.7) 492.7 (415.4–577.2) 26.7 (21.7–32) 0.019 (–0.016–0.054)
Georgia 1833.3 (1624.3–2082.4) 32.1 (28.3–36.2) 1247.7 (1080–1405.3) 31.6 (27.3–35.5) −0.059 (–0.091 to −0.026)
Germany 29343.9 (26426.2–32070.5) 33.7 (30.6–36.8) 25398.9 (22962.1–27925.6) 28.8 (26.2–31.4) −0.532 (–0.588 to −0.477)
Ghana 3065.5 (2488.6–3698.3) 24.2 (18.6–30.6) 6227 (5170.6–7376.8) 21.9 (17.7–26.4) −0.373 (–0.418 to −0.328)
Greece 2627.2 (2262.8–2991) 22.9 (19.8–26) 1803.4 (1567.3–2039.2) 15.8 (13.7–17.6) −1.286 (–1.352 to −1.219)
Greenland 9.9 (8.6–11.1) 15.1 (13.1–17) 9.1 (7.8–10.4) 16 (13.8–17.9) 0.191 (0.16–0.222)
Grenada 13.2 (11.3–15.3) 20.6 (17.2–24.1) 24.3 (20–28.5) 21.3 (18–24.7) 0.116 (0.081–0.151)
Guam 30.7 (25.7–35.9) 22.3 (18.5–26.1) 31.8 (26.4–37.5) 19.2 (16.2–22.3) −0.548 (–0.675 to −0.421)
Guatemala 2898.9 (2525.1–3271.2) 46.1 (39.5–52.8) 8092.3 (7089.4–9165.3) 52 (45.2–58.9) 0.435 (0.384–0.486)
Guinea 1262.3 (1005.8–1546.8) 23.2 (17.1–29.8) 2419 (2037.3–2833.5) 22.5 (18.1–27) −0.065 (–0.211 to 0.081)
Guinea–Bissau 238.9 (193.8–289.3) 28.7 (21.5–36.5) 429.9 (354.9–512.9) 25.8 (20.2–31.5) −0.386 (–0.437 to −0.334)
Guyana 214.7 (178.6–249.7) 34 (27.6–40.3) 262.8 (217.3–304.8) 34 (28.2–39.4) −0.027 (–0.098–0.045)
Haiti 1084.3 (852.8–1321.7) 21.2 (15.9–26.6) 2778.6 (2254.1–3349.8) 25.3 (20.3–30.8) 0.607 (0.578–0.635)
Honduras 1361.8 (1174.4–1558.7) 40.1 (33.9–46.7) 3080.4 (2548.6–3573.6) 36.6 (30.1–42.9) −0.299 (–0.331 to −0.267)
Hungary 6257.7 (5687.6–6872.3) 56.2 (51.3–61.3) 3701 (3293.1–4087) 32 (29–35) −1.939 (–2.035 to −1.843)
Iceland 23.3 (20.3–26.1) 9 (7.9–10.1) 33.5 (29.1–37.5) 9.6 (8.4–10.8) 0.229 (0.173–0.286)
India 138576.4 (101108.2–183003.6) 16.3 (11–22.1) 326903.9 (231217.7–432794) 23.2 (16.5–30.6) 1.285 (1.18–1.39)
Indonesia 47107.3 (30183.3–66201.9) 29.9 (17.3–43.7) 64125.6 (39655.2–88214.1) 23.2 (14.5–32.3) −0.867 (–1.071 to −0.662)
Iran (Islamic Republic of) 6502.4 (4915.4–8376.8) 14.2 (9.7–19.4) 14346 (10406.8–18651.6) 16.6 (12.1–21.7) 0.531 (0.446–0.616)
Iraq 2161.7 (1832.5–2516.8) 16.1 (13.2–19.3) 6593.1 (5692.1–7553.6) 18.3 (15.5–21.1) 0.452 (0.387–0.518)
Ireland 391.5 (344.1–435.1) 11.3 (9.9–12.5) 826 (720.8–931.3) 15.4 (13.6–17.2) 1.073 (1.036–1.111)
Israel 826.6 (725.9–926.7) 18.7 (16.4–20.9) 1588.8 (1371.7–1802.6) 17.3 (14.9–19.6) −0.291 (–0.359 to −0.224)
Italy 30032.3 (23039.5–37582.4) 48 (37.3–59.5) 24482.7 (19411.1–30069.1) 32.7 (26.6–39.1) −1.285 (–1.341 to −1.23)
Jamaica 196.2 (168.6–224.4) 10.2 (8.7–11.8) 246.2 (208.4–285.8) 8.5 (7.3–9.8) −0.604 (–0.653 to −0.555)
Japan 46734 (34542.6–59459.2) 31.1 (23.9–39.1) 33114.8 (25347.4–41069.2) 25.9 (21–31.3) −0.61 (–0.73 to −0.489)
Jordan 424.5 (356.9–500.7) 16.3 (13.4–19.7) 1763.5 (1510.2–2044.7) 17.4 (14.8–20.4) 0.233 (0.199–0.266)
Kazakhstan 3469.9 (3027.9–3930.8) 22.6 (19.7–25.6) 12698.3 (11180.6–14267.1) 63.3 (55.6–71.2) 3.632 (3.505–3.759)
Kenya 5233.6 (3699.3–6934.3) 34 (19.6–50) 14848.4 (10357.3–19692.6) 36.5 (22.2–52.3) 0.261 (0.143–0.379)
Kiribati 13.6 (10.3–17.3) 19.6 (14.6–25.2) 20 (15.5–24.9) 17.4 (13.3–21.8) −0.414 (–0.463 to −0.365)
Kuwait 174.8 (145.7–203) 10.7 (9–12.3) 755.7 (630.4–884.2) 15.2 (13—7.4) 1.226 (1.181–1.271)
Kyrgyzstan 1311.3 (1142.5–1495) 35.9 (30.8–41.5) 3182.6 (2821.6–3608.4) 48.9 (43.2–55.4) 1.07 (0.99–1.15)
Lao People’s Democratic Republic 739.5 (585–895.4) 22.6 (17.4–27.9) 1683.1 (1375.9–2009.8) 24.9 (20.2–29.9) 0.326 (0.285–0.368)
Latvia 360.5 (315.5–405.3) 13.7 (12–15.3) 353.7 (311–395.8) 20 (17.9–22.3) 1.343 (1.268–1.419)
Lebanon 469.6 (389.1–564.4) 15.9 (13–19.5) 1109.6 (927.7–1312.7) 21.3 (17.8–25.3) 1.013 (0.961–1.065)
Lesotho 343.4 (275.8–422.6) 22.7 (17.3–28.6) 431.8 (340.5–536.9) 20.6 (15.9–25.8) −0.342 (–0.394 to −0.29)
Liberia 315.4 (247.1–396.2) 18.2 (13–24.2) 897.2 (740.3–1075.2) 21.3 (17–26) 0.598 (0.487–0.709)
Libya 548 (457.9–645.9) 17.8 (14.2–22.1) 1142.4 (943.4–1338.4) 17.1 (14.3–20.4) −0.124 (–0.176 to −0.072)
Lithuania 529.6 (467.6–591) 14.5 (12.9–16.2) 677.8 (607–744.7) 27.8 (25–30.6) 2.268 (2.029–2.507)
Luxembourg 157.9 (140.9–174.2) 36.3 (32.5–40.2) 196.1 (171.5–219.8) 26.4 (23.2–29.3) −1.141 (–1.257 to −1.025)
Madagascar 1900.9 (1505.1–2332) 19.9 (14.4–26.4) 5724.3 (4774.8–6766.8) 25.3 (20.4–30.4) 0.844 (0.765 –0.923)
Malawi 2095.8 (1742.5–2517.5) 29.6 (22.8–37.2) 3866 (3200.7–4606.7) 27.7 (21.8–34.6) −0.229 (–0.294 to −0.164)
Malaysia 2622.6 (2170.9–3059) 17.8 (14.6–21.1) 6861.1 (5848.4–7993.4) 21.1 (17.9–24.6) 0.58 (0.519–0.641)
Maldives 19.9 (16.1–24.2) 12.7 (10.1–15.6) 76.1 (63.6–89.5) 13.8 (11.6–16.1) 0.296 (0.259–0.334)
Mali 1683.6 (1344.7–2086.5) 21.5 (15.5–28.6) 5093.2 (4247.7–6067.8) 28 (21.8–34.5) 0.897 (0.834–0.961)
Malta 66.9 (58.6–74.8) 16.1 (14.2–17.9) 61.1 (53.9–68.1) 13.5 (12–15) −0.602 (–0.65 to −0.554)
Marshall Islands 6.9 (5.6–8.5) 19 (14.8–23.6) 9.8 (7.8–11.9) 16.8 (13.3–20.3) −0.444 (–0.493 to −0.394)
Mauritania 432.6 (363.1–510.4) 24.8 (19.5–30.5) 826 (690.2–979) 23.8 (19.4–28.9) −0.151 (–0.211 to −0.09)
Mauritius 315 (269.6–357.6) 28 (23.8–32) 252.6 (216.2–292) 17.8 (15.4–20.3) −1.585 (–1.892 to −1.277)
Mexico 39192.5 (28579.5–50933.8) 58.8 (41.2–77.7) 73785.2 (55023.3–93216.2) 55.4 (41.4–69.9) −0.174 (–0.225 to −0.123)
Micronesia (Federated States of) 17.3 (13.7–21.2) 20.2 (15.6–25.1) 18.7 (14.9–22.7) 18.8 (15.1–23) −0.286 (–0.401 to −0.171)
Monaco 7.4 (6.3–8.4) 21.9 (18.9–24.7) 8.6 (7.3–10) 23.8 (20.7–26.6) 0.273 (0.253–0.292)
Mongolia 816.8 (676.2–968) 52.1 (42.1–63.2) 2950.8 (2468.2–3491.8) 79.6 (66.4–94.2) 1.479 (1.335–1.622)
Montenegro 68 (59.1–76.9) 10.8 (9.4–12.2) 66.6 (56.9–75.4) 10.6 (9.1–12) −0.045 (–0.079 to −0.011)
Morocco 3296.2 (2729.5–3961) 16.6 (13.2–20.8) 6917.5 (5691.9–8264) 18.8 (15.6–22.6) 0.447 (0.401–0.492)
Mozambique 1754.9 (1419.5–2135.5) 16.1 (12.3–20.4) 4206.3 (3449.4–5027.6) 17.7 (13.8–22.4) 0.328 (0.298–0.359)
Myanmar 12459.9 (9800.2–15229.5) 34.5 (26.3–42.4) 19740.1 (16363.4–23090.3) 34.3 (28.5–40) −0.034 (–0.098–0.03)
Namibia 236.4 (190.9–281.9) 20.6 (15.7–25.6) 492.6 (404.1–581.9) 21.9 (17.7–26.4) 0.201 (0.111–0.292)
Nauru 1.5 (1.2–1.9) 16.2 (12.6–20) 1.8 (1.4–2.2) 17.4 (13.9–20.9) 0.225 (0.129–0.322)
Nepal 3745.8 (3102.7–4417.4) 20 (16.1–24.3) 7106.8 (5950.4–8378.4) 24.3 (20.2–28.9) 0.675 (0.604–0.746)
Netherlands 2751.7 (2402.3–3123.6) 16.6 (14.5–18.8) 2786.8 (2408.9–3209.2) 15.3 (13.3–17.3) −0.29 (–0.334 to −0.246)
New Zealand 318.9 (229.3–411.9) 9.1 (6.6–11.8) 438.2 (330.2–559) 8.7 (6.8–10.8) −0.148 (–0.169 to −0.126)
Nicaragua 838.8 (736.9–945.8) 30.5 (26.2–34.5) 2395.9 (2082.8–2688.6) 37.9 (32.9–42.7) 0.763 (0.682–0.845)
Niger 1939 (1594.7–2348.5) 29.4 (22.2–37.6) 5636 (4687.8–6724.5) 30.8 (24–38.4) 0.145 (0.098–0.191)
Nigeria 17729.5 (12682.4–23418.8) 23.4 (14.3–33.9) 47955.3 (35981–61740.1) 27.1 (17.8–37.2) 0.522 (0.439–0.605)
Niue 0.3 (0.2–0.4) 14.4 (11.7–17.2) 0.2 (0.2–0.3) 14.7 (12.1–17.3) 0.051 (–0.067–0.17)
North Macedonia 353.4 (305.8–398.6) 17.1 (14.8–19.3) 500.2 (438.7–556.2) 19.8 (17.3–21.9) 0.513 (0.485–0.541)
Northern Mariana Islands 17.4 (13.7–21) 33.2 (26.2–40.2) 14.2 (10.8–18.3) 29.8 (24.5–35.5) −0.392 (–0.635 to −0.148)
Norway 701 (526.7–884.4) 16.1 (12.3–20.1) 835 (629.7–1050.7) 15.1 (11.8–18.7) −0.111 (–0.234–0.012)
Oman 317.8 (269–377.3) 23.9 (19.3–29) 1036.5 (858.9–1229.7) 29.3 (24.2–35.2) 0.633 (0.4–0.865)
Pakistan 24805.7 (18362.2–32278.6) 25.1 (16.4–34.4) 50880.2 (37887.4–66260.7) 25.1 (17–33.9) 0.008 (–0.007–0.023)
Palau 2.4 (1.9–2.9) 15.4 (12.3–18.6) 3.6 (2.8–4.4) 17 (13.9–20.3) 0.316 (0.222–0.411)
Palestine 272.4 (231.3–320.1) 18.8 (15.4–22.6) 821.2 (707.3–957.4) 21.6 (18.3–25.5) 0.502 (0.362–0.643)
Panama 425.7 (368.8–484.5) 21.6 (18.5–24.6) 950 (827.5–1063.9) 22.3 (19.4–24.9) 0.133 (0.069–0.196)
Papua New Guinea 236.5 (185.3–286.4) 6 (4.7–7.3) 617.3 (500.5–739) 6.1 (4.9–7.2) 0.036 (0.013–0.059)
Paraguay 471 (402.9–539.3) 15 (12.7–17.4) 1062.9 (906.8–1226) 15.7 (13.3–18.2) 0.156 (0.138–0.174)
Peru 4297.5 (3756.2–4899.9) 24.1 (20.5–28.1) 10145.3 (8729.6–11717.3) 29.4 (25.3–33.9) 0.679 (0.533–0.825)
Philippines 8344.5 (5828.1–10959.2) 15.9 (10.4–21.6) 21019.1 (15022.8–27539.8) 19.6 (13.6–25.9) 0.726 (0.697–0.756)
Poland 9550.3 (7025.7–12367.6) 23.7 (17.3–30.4) 8644.4 (6080.3–11391.3) 21.1 (15.7–27.1) −0.391 (–0.468 to −0.314)
Portugal 3889.6 (3428.5–4295.7) 37.6 (33–41.4) 2238.9 (1935.1–2532.8) 18.5 (16.3–20.5) −2.433 (–2.542 to −2.324)
Puerto Rico 1216.4 (1051.4–1381.1) 33.9 (29.4–38.5) 948.1 (814.1–1084.5) 24.4 (20.9–27.4) −1.142 (–1.214 to −1.07)
Qatar 102.4 (83.7–123.6) 31.2 (24.8–38.6) 934.2 (774.3–1107.3) 39.4 (32.4–47.9) 0.782 (0.696–0.868)
Republic of Korea 30126.5 (26539.9–33492.2) 67.5 (58.8–75.4) 16886.5 (14580.1–19355.5) 25.5 (22.5–28.9) −3.345 (–3.548 to −3.14)
Republic of Moldova 4338.6 (4021–4620.4) 98.5 (90.6–105.6) 3504.2 (3160.8–3776.6) 80 (71.7–86.3) −0.723 (–0.834 to −0.612)
Romania 11829.8 (10829.5–12867.3) 49.1 (44.8–54.1) 12134.7 (11012.3–13100.8) 51.2 (46.9–55.2) 0.16 (0.045–0.275)
Russian Federation 28493.8 (20826.9–37066.2) 18.3 (13.4–23.6) 45082.2 (30894.5–61098.7) 29.9 (21.6–39.4) 1.734 (1.629–1.839)
Rwanda 1688.6 (1373–2052.3) 30.4 (22.8–38.8) 3382.7 (2780.2–4007.9) 32.4 (25.6–39.4) 0.226 (0.18–0.271)
Saint Kitts and Nevis 8.7 (7.3–10) 29.1 (23.8–34.4) 18.3 (15.1–21.3) 25.1 (20.9–28.8) −0.522 (–0.57 to −0.473)
Saint Lucia 23.2 (19.8–26.7) 22.3 (18.6–26.1) 39.8 (33.5–46.2) 19.2 (16.4–22) −0.518 (–0.597 to −0.439)
Saint Vincent and the Grenadines 13.3 (11.4–15.4) 16 (13.5–18.9) 18.6 (15.6–21.8) 15.2 (12.9–17.6) −0.178 (–0.244 to −0.112)
Samoa 23.1 (19.2–27.1) 17.7 (14.4–21.2) 33.7 (27.8–39.8) 17.5 (14.5–20.9) −0.028 (–0.071–0.015)
San Marino 9 (7.8–10.1) 36.6 (31.9–41.2) 12.1 (10.3–13.7) 33.1 (29–36.9) −0.389 (–0.453 to −0.325)
Sao Tome and Principe 38 (32.2–45.1) 36.8 (29.6–44.9) 62.9 (52.3–74.7) 33.5 (27.1–40.3) −0.333 (–0.372 to −0.294)
Saudi Arabia 2998.5 (2514.1–3517.2) 29.8 (23.6–36.9) 10224.5 (8517–11958.4) 32.5 (26.9–38.5) 0.305 (0.255–0.354)
Senegal 1672.4 (1407.8–1961.5) 26.3 (20.4–32.1) 3594.2 (2980.6–4281.3) 27.4 (21.9–33) 0.145 (0.122–0.167)
Serbia 1975.1 (1691.1–2223.8) 19.8 (17–22.2) 1640.8 (1451.3–1826.5) 17.7 (15.8–19.6) −0.366 (–0.413 to −0.319)
Seychelles 17.3 (14.5–20.3) 28.1 (22.8–33.4) 34.7 (28.8–40.8) 28.3 (23.7–32.8) 0.011 (–0.042–0.064)
Sierra Leone 595 (471.3–731.4) 18.2 (13.3–23.8) 1747.1 (1445.8–2065.2) 24.4 (19.6–29.6) 1.034 (0.956–1.112)
Singapore 560.6 (493.1–629.7) 17 (15–19.1) 747.6 (636.6–857.7) 11.2 (9.8–12.6) −1.434 (–1.527 to −1.34)
Slovakia 2042.8 (1831.6–2245.6) 36.5 (32.6–40) 2056.9 (1808.9–2296.6) 32.6 (29–36.1) −0.38 (–0.398 to −0.363)
Slovenia 992.6 (883.7–1076.4) 46.1 (40.8–49.8) 740 (668.9–812.5) 31.1 (28–34) −1.367 (–1.459 to −1.274)
Solomon Islands 63.9 (50.9–77.3) 21.9 (17.1–27.2) 132.8 (108.5–158.9) 20.6 (16.7–24.8) −0.217 (–0.301 to −0.133)
Somalia 1548.3 (1170.8–1965.5) 29 (19.8–40.3) 4398.1 (3505.5–5329.3) 29.7 (21.4–39.1) 0.111 (0.045–0.177)
South Africa 6346.7 (4603–8240.3) 18.5 (12.3–24.9) 7807.5 (5523.8–10344) 13.8 (9.6–18.3) −1.031 (–1.119 to −0.942)
South Sudan 953.9 (762.5–1153.7) 21.7 (16–27.9) 1705.5 (1343.3–2093) 23 (17.2–29.4) 0.225 (0.132–0.318)
Spain 15287.3 (13838.9–16797.6) 39 (35.3–43) 13480.1 (11838.4–15148) 23.3 (20.6–25.9) −1.78 (–1.945 to −1.614)
Sri Lanka 4156.9 (3483.3–4783.3) 24.7 (20.7–28.6) 5600.8 (4693.8–6530.8) 23.3 (19.7–26.8) −0.248 (–0.345 to −0.151)
Sudan 1954.9 (1514.9–2478.2) 12.7 (9–17.2) 4800.6 (3939.4–5755.5) 15.8 (12.4–19.8) 0.755 (0.543–0.969)
Suriname 74.3 (63.1–86.3) 22.3 (18.8–26.2) 151.2 (125.8–179.3) 23.7 (20–27.6) 0.196 (0.092–0.301)
Sweden 1238.3 (908.1–1580) 13.6 (10.3–17.2) 1605.4 (1217.3–2012.1) 15.3 (12–19) 0.432 (0.346–0.517)
Switzerland 1468.5 (1293.6–1645.3) 18.6 (16.5–20.9) 1747.1 (1526.4–1982.6) 17.5 (15.5–19.6) −0.293 (–0.387 to −0.199)
Syrian Arab Republic 1902.8 (1634.9–2196.3) 20.1 (16.4–23.9) 3557.6 (2967.6–4203.1) 24 (20.3–28.3) 0.617 (0.589–0.645)
Taiwan (Province of China) 9075.2 (7704.6–10231.4) 44.7 (37.6–51.3) 8204.8 (7102.7–9258.7) 26.6 (23–29.9) −1.814 (–1.969 to −1.658)
Tajikistan 1251.9 (1096–1425.3) 28.9 (24.8–33.1) 4716.5 (4028.7–5447.5) 53.8 (45.9–62.3) 2.167 (2.102–2.231)
Thailand 12333.2 (10221.8–14514.2) 22 (17.9–25.9) 20264.9 (17000.3–23767.8) 24.2 (20.7–27.9) 0.3 (0.157–0.443)
Timor–Leste 140.4 (110.4–170.4) 21.8 (16.8–27) 275.5 (224.6–330.6) 26.4 (20.9–32) 0.668 (0.633–0.704)
Togo 736.9 (618.4–870.1) 24.4 (18.9–30.2) 1880.5 (1518.2–2275.9) 26.6 (21–32.7) 0.297 (0.265–0.328)
Tokelau 0.2 (0.1–0.2) 12.1 (9.9–14.4) 0.2 (0.1–0.2) 12.4 (10.2–14.6) 0.069 (0.044–0.095)
Tonga 15.9 (13–19.1) 21.1 (16.8–25.5) 18.5 (15.2–22.1) 20.1 (16.5–23.9) −0.189 (–0.251 to −0.127)
Trinidad and Tobago 168.1 (145.2–192.5) 15.1 (12.9–17.5) 201.8 (170.3–231.5) 13.2 (11.2–15.1) −0.483 (–0.521 to −0.445)
Tunisia 1153.7 (957.9–1380.8) 17 (13.6–20.8) 2680.9 (2211.4–3208.3) 20.7 (17.3–24.6) 0.686 (0.64–0.731)
Turkey 6651.2 (5554.3–7838.4) 13.1 (10.9–15.7) 16568.3 (14288.5–19074) 18.7 (16.2–21.5) 1.252 (1.156–1.348)
Turkmenistan 1188.5 (1036.1–1344.9) 40.5 (34.7–46.5) 2843.1 (2491.8–3203.5) 53.3 (46.7–60.2) 0.921 (0.764–1.078)
Tuvalu 1.2 (0.9–1.4) 13.1 (10.4–15.7) 1.6 (1.3–1.9) 14.3 (11.7–16.9) 0.303 (0.239–0.367)
Uganda 2791.9 (2300.7–3351.1) 23 (17.6–28.9) 6934 (5750–8290.5) 23.4 (18.2–29.6) 0.07 (0.038–0.102)
Ukraine 10702.4 (7653.6–14131.9) 20.7 (15–27.2) 14401.2 (9090.2–21069.5) 33.7 (22.6–47.3) 1.663 (1.501–1.824)
United Arab Emirates 219.5 (178.5–266.2) 16.5 (13.2–20.2) 2019.1 (1587.4–2473.4) 18 (14.9–21.6) 0.307 (0.253–0.362)
United Kingdom 8657.4 (6713.8–10658.1) 14.9 (11.7–18.3) 16129.7 (13136.1–19379) 23.9 (19.8–28.4) 1.668 (1.456–1.882)
United Republic of Tanzania 4065.5 (3449.9–4751.3) 21.2 (17.3–25.6) 10011 (8280.3–11940.5) 22.2 (17.6–27.5) 0.142 (0.083–0.201)
United States of America 65860.2 (50497.6–82940.7) 23.8 (18.1–30) 90854.4 (73757.5–108952.6) 26.3 (21.8–31.2) 0.369 (0.213–0.526)
United States Virgin Islands 25.1 (20.6–29.8) 22.1 (18.5–25.9) 27.5 (22.8–32.9) 24.1 (20.3–27.9) 0.289 (0.25–0.328)
Uruguay 580.3 (507.4–660.6) 18.7 (16.3–21.2) 637.3 (548.6–721.1) 17.1 (14.7–19.3) −0.311 (–0.378 to −0.244)
Uzbekistan 6750.2 (5980.7–7600.9) 41.7 (36–48) 22488.6 (19881.9–25080.7) 65.2 (57.6–72.9) 1.57 (1.427–1.713)
Vanuatu 33.4 (26.8–40.2) 25.9 (19.9–32.2) 61.8 (49.1–74.3) 23.1 (18.1–28.1) −0.397 (–0.45 to −0.344)
Venezuela (Bolivarian Republic of) 3887.7 (3421–4342.4) 25.4 (22.1–28.4) 6248.9 (5380.9–7078.2) 20.1 (17.5–22.8) −0.812 (–0.859 to −0.766)
Viet Nam 13537.6 (11280.1–15929.3) 26.3 (21.4–31.5) 32979.7 (28013.8–38176.4) 29.3 (25.1–33.7) 0.381 (0.3–0.463)
Yemen 1737 (1440.8–2108.4) 18.3 (13.7–23.9) 4660.3 (3931–5457.4) 20.2 (16.5–24.4) 0.338 (0.288–0.389)
Zambia 1839.1 (1519–2198.3) 31.8 (24.4–39.6) 4513 (3781.4–5296.7) 32.2 (26–39) 0.041 (0.021–0.061)
Zimbabwe 1753.3 (1477–2069.9) 21.4 (17.4–26.5) 2657.4 (2177.9–3199.5) 20.1 (15.8–25) −0.197 (–0.337 to −0.058)

ASR: age–standardized rate; CI: confidence interval; AAPC: average annual percent change; UI: uncertainty interval.Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

Furthermore, the mortality burden of liver cirrhosis was analysed by countries and regions in 2019. Egypt had the highest age–standardized death rate (ASDR) (126.7 per 100000, 95% UI: 87.3 − 169.5), followed by Mongolia (72.9 per 100000, 95% UI: 56.9 − 91.3). However, Singapore (3.3 per 100000, 95% UI: 2.9 − 3.6) and Iceland (3.3 per 100000, 95% UI: 2.9 − 3.7) had the lowest ASDR globally (Figure 2 (A) and Table 3). The change in the number of deaths from cirrhosis from 1990 to 2019 also shows large differences across countries. The number of deaths from cirrhosis in the United Arab Emirates increased by 607.7% from 71.4 in 1990 to 505.6 in 2019. In Portugal, however, there was a 42.8% decrease, from 3,658.6 cases in 1990 to 2,091.7 cases in 2019 (Figure 2(B) and Table 3). EAPC analysis found that Belarus and Lithuania had the fastest annual average growth rate of 3.7% (95%CI: 2.6 − 4.9; 95%CI: 2.6 − 4.8;). However, the Republic of Korea experienced the fastest annual decrease in ASDR of 5.6% (95% CI: −5.9 to −5.2) globally (Figure 2(C) and Table 3).

Figure 2.

Figure 2.

Disease burden of cirrhosis mortality in 204 countries and territories worldwide: A. ASR for cirrhosis mortality in 2019; B. Changes in the cases of cirrhosis from 1990 to 2019; C. EAPC analysis of cirrhosis ASR from 1990 to 2019. ASR, age-standardized rate; EAPC, estimated annual percent change. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

Table 3.

ASDR, change in case numbers and EAPC for cirrhosis in different countries.

Country ASDR per 100,000
NO. (95% UI)
Cases change
EAPC
NO. (95%CI)
Case_1990 Case_2019 Cases change
(%)
Afghanistan 27.5 (18.8–36.7) 2673.5 3797.4 42 −1.2 (–1.3 to –1)
Albania 8.2 (5.9–11.1) 326.4 332.7 1.9 −2.1 (–2.4 to –1.7)
Algeria 13.7 (10.6–17.4) 2401 4044.9 68.5 −1.7 (–1.8 to –1.7)
American Samoa 14.3 (11.6–17.4) 4.8 6.9 44.4 −0.9 (–1.1 to –0.8)
Andorra 8.6 (6.4–11.3) 6.2 12.2 96.8 −1 (–1.1 to –0.9)
Angola 44.5 (35.3–55.7) 2782.2 5665.6 103.6 −1.1 (–1.2 to –1.1)
Argentina 16.2 (14.9–17.5) 5942.6 8524.5 43.4 −0.3 (–0.5 to –0.2)
Armenia 28 (23.6–32.6) 405.7 1114.2 174.6 2.8 (2.2–3.4)
Australia 5.8 (5.3–6.3) 1394.5 2214.8 58.8 −0.7 (–0.9 to –0.5)
Austria 11.3 (10.5–12.1) 2253.1 1809.4 −19.7 −2.3 (–2.4 to –2.3)
Azerbaijan 38.1 (29.4–48.1) 1560.3 3118 99.8 0.2 (–0.3–0.6)
Bahamas 15.1 (12.3–18.6) 39.7 61.5 54.9 −1.7 (–1.9 to –1.5)
Bahrain 18.3 (14–23.3) 50.1 138.3 176.4 −2.3 (–2.6 to –2.1)
Bangladesh 20.2 (15.8–25.6) 26628.4 26164.6 −1.7 −3 (–3.3 to –2.7)
Barbados 9.9 (7.9–12) 35.7 46.7 31.1 −1.4 (–1.6 to –1.2)
Belarus 15.5 (11.9–20.3) 836.7 2234.6 167.1 3.7 (2.6–4.9)
Belgium 10.1 (9.2–11) 1765.6 2105.2 19.2 −0.8 (–0.9 to –0.7)
Belize 21.8 (18.9–25.2) 20.1 65.5 225.8 0 (–0.4–0.3)
Benin 34.8 (27.1–45.1) 1145 1943.1 69.7 −1.5 (–1.7 to –1.3)
Bermuda 6.4 (5.2–7.9) 9.9 7.9 −20.2 −3.3 (–3.7 to –2.9)
Bhutan 29.8 (19.8–56.5) 111.2 176.3 58.6 −0.6 (–0.7 to –0.5)
Bolivia 38.2 (28.5–49.5) 1487.3 3318.8 123.1 −0.5 (–0.6 to –0.5)
Bosnia and Herzegovina 10.3 (8–13.2) 758.7 593.3 −21.8 −2.3 (–2.6 to –2.1)
Botswana 26.5 (19–35.8) 231.4 417.7 80.5 −1.7 (–2.1 to –1.3)
Brazil 15.8 (14.9–16.9) 24474 38028.6 55.4 −1.5 (–1.5 to –1.4)
Brunei Darussalam 9.2 (7.8–10.7) 18 31.2 73 −2 (–2.2 to –1.7)
Bulgaria 22.5 (17.5–28.3) 2246.2 2707.1 20.5 0.3 (0.1–0.5)
Burkina Faso 30.1 (17.8–42.8) 2275.6 2993 31.5 −2.3 (–2.6 to –2)
Burundi 37.8 (22.8–62.7) 1458.6 1905.7 30.7 −1.9 (–2.1 to –1.7)
Cabo Verde 25.2 (21.1–30) 58.8 114.3 94.3 −0.8 (–1.1 to –0.5)
Cambodia 67.4 (54.1–81.5) 4703.6 8387.8 78.3 −1 (–1 to –0.9)
Cameroon 30.2 (20.6–42.7) 2283.2 4130.8 80.9 −1.7 (–2 to –1.5)
Canada 8.4 (7.6–9.2) 3144.3 5442 73.1 −0.6 (–0.7 to –0.6)
Central African Republic 43.3 (28.6–65.6) 740.6 1105.3 49.2 −0.9 (–1 to –0.8)
Chad 44.3 (34.4–56.9) 1429 2885.6 101.9 −0.2 (–0.3 to –0.1)
Chile 21.7 (20.2–23.2) 3929.5 5157.3 31.2 −1.7 (–1.8 to –1.6)
China 7.8 (6.6–9.2) 167670.7 152261.9 −9.2 −3.1 (–3.3 to –3)
Colombia 7.5 (5.7–9.7) 2098.3 3984.5 89.9 −2 (–2.1 to –1.8)
Comoros 32.5 (21.5–47) 89 161.1 81 −0.8 (–0.9 to –0.6)
Cook Islands 8.4 (6.4–10.5) 1.9 2 5.7 −1.9 (–2 to –1.7)
Costa Rica 18.5 (14.3–23.5) 317.2 959.6 202.5 −0.3 (–0.6 to –0.1)
Côte d’Ivoire 32 (21.6–43.4) 2280.4 3947.6 73.1 −1.6 (–1.8 to –1.4)
Croatia 14.6 (11.4–18.5) 1882.7 1150.7 −38.9 −2.6 (–2.8 to –2.4)
Cuba 11.1 (8.8–13.7) 1127.1 2035.8 80.6 −0.1 (–0.4–0.2)
Cyprus 7.8 (6.7–9.2) 102.3 140.4 37.2 −2.5 (–2.7 to –2.4)
Czech Republic 12.9 (10.4–15.8) 2287.4 2319.7 1.4 −0.7 (–0.9 to –0.5)
Democratic Republic of the Congo 34.5 (24.4–45.8) 8622.5 14392.7 66.9 −1.3 (–1.3 to –1.2)
Denmark 9.6 (8.7–10.5) 770.1 954.7 24 −1.2 (–1.6 to –0.7)
Djibouti 35.3 (22.2–55.1) 68.1 226 231.8 −0.7 (–0.7 to –0.6)
Dominica 12.4 (9.8–15.5) 11.8 10.9 −8 −1.3 (–1.4 to –1.2)
Dominican Republic 31.7 (23.5–42.1) 1530 2945.2 92.5 −0.9 (–1.4 to –0.5)
Ecuador 26.5 (20.7–33.7) 1472.9 3904.7 165.1 0.4 (0.1–0.6)
Egypt 126.7 (87.3–169.5) 39203.3 62635.4 59.8 −0.8 (–0.9 to –0.6)
El Salvador 25.1 (19–32.5) 970.6 1500 54.5 −0.8 (–1 to –0.6)
Equatorial Guinea 23 (15.2–35.4) 91.7 126.2 37.6 −2.4 (–2.6 to –2.2)
Eritrea 52.9 (39.9–70.8) 610.4 1572.3 157.6 −0.1 (–0.3–0.1)
Estonia 13.9 (10.5–17.8) 143.2 277.2 93.5 1.8 (0.9–2.7)
Eswatini 29.1 (21–39.7) 115.3 189.5 64.4 −0.5 (–0.8 to –0.1)
Ethiopia 52.2 (44.2–62.1) 16794 22772.5 35.6 −1.5 (–1.6 to –1.4)
Fiji 11.4 (8.9–14.3) 62.2 86.5 39 −0.9 (–1 to –0.8)
Finland 12.3 (11.3–13.3) 619.5 1152.2 86 1.6 (1.1–2)
France 8.9 (8.2–9.7) 13685.9 10722.4 −21.7 −2.6 (–2.7 to –2.5)
Gabon 35.9 (25.3–47.2) 301.6 397.2 31.7 −1.3 (–1.4 to –1.2)
Gambia 34.1 (24–45.5) 173.5 357.4 106 −1.2 (–1.4 to –1)
Georgia 29.3 (24.3–34.9) 1719.4 1562 −9.2 0.4 (0.2–0.6)
Germany 12.3 (11.4–13.3) 22262.8 20491.6 −8 −2.1 (–2.3 to –1.9)
Ghana 34.9 (26.3–44.7) 4065.8 6124.5 50.6 −2 (–2.1 to –1.9)
Greece 6.2 (5.7–6.7) 1748.3 1366.4 −21.8 −2.4 (–2.7 to –2.2)
Greenland 11.5 (8.9–14.4) 6 8.6 43.6 −0.4 (–0.5 to –0.3)
Grenada 16.1 (14.1–18.2) 15.6 18.3 17.4 −1.3 (–1.5 to –1.2)
Guam 17.6 (14.6–21) 20.5 33 60.8 −1.5 (–1.7 to –1.2)
Guatemala 45.8 (36.1–57.5) 2345.7 5520.7 135.4 −0.7 (–0.9 to –0.5)
Guinea 38.5 (27.8–52.1) 1686.1 2381.9 41.3 −0.6 (–0.8 to –0.5)
Guinea–Bissau 53.1 (39.7–68.4) 298.5 449.4 50.5 −0.6 (–0.6 to –0.5)
Guyana 37 (28.8–46.9) 218.5 250.9 14.8 −0.8 (–1 to –0.6)
Haiti 28.2 (14.8–39.9) 1474.5 2151.4 45.9 −1.1 (–1.3 to –1)
Honduras 49 (33.1–67.7) 1124.6 2952.2 162.5 0.4 (0.2–0.5)
Hungary 21.1 (17.2–25.6) 5950.8 3510.5 −41 −3.8 (–4.3 to –3.4)
Iceland 3.3 (2.9–3.7) 12.7 16.9 33.2 −1.5 (–1.5 to –1.4)
India 22.5 (19.1–26.8) 144247.3 270036.8 87.2 −0.6 (–0.8 to –0.4)
Indonesia 43.7 (36.8–49.3) 57982.7 88670.1 52.9 −0.6 (–0.7 to –0.5)
Iran 9.9 (8.8–11.1) 3999.1 6831.7 70.8 −1.4 (–1.5 to –1.2)
Iraq 11.8 (9.3–14.4) 1490.1 2720.1 82.5 −1.4 (–1.5 to –1.3)
Ireland 5.5 (5–6.1) 194.9 388.5 99.3 0.5 (0.1–1)
Israel 6.5 (5.8–7.5) 399.1 756 89.4 −1.5 (–1.9 to –1.2)
Italy 8.8 (8.2–9.3) 18129.4 12450.5 −31.3 −3.3 (–3.4 to –3.2)
Jamaica 6.1 (4.7–7.7) 155.6 185.1 19 −1.5 (–1.8 to –1.1)
Japan 7.6 (6.9–8.2) 25310.2 26248.4 3.7 −2.4 (–2.5 to –2.3)
Jordan 11 (8.9–13.3) 247.1 644.1 160.6 −2.3 (–2.5 to –2.1)
Kazakhstan 37.5 (31.9–45) 2184.3 6705 207 3.4 (2.8–4)
Kenya 57.5 (41.7–80.6) 5429.6 13094.9 141.2 −0.1 (–0.3–0.1)
Kiribati 34.5 (19.8–52.3) 23.6 27.1 14.5 −1.8 (–1.9 to –1.6)
Kuwait 7.9 (6.5–9.5) 60.9 203.9 234.7 0.1 (–0.6–0.7)
Kyrgyzstan 40.9 (36–46.6) 1024.4 2143.1 109.2 0.7 (0.1–1.4)
Laos 26.5 (19–35.6) 896.3 1272.8 42 −1.5 (–1.6 to –1.3)
Latvia 12.9 (10.4–16) 248.1 387.9 56.3 1.6 (0.9–2.3)
Lebanon 11.6 (7.2–18.5) 357.9 596.3 66.6 −1.3 (–1.4 to –1.2)
Lesotho 28.6 (19.5–39.3) 307.8 395 28.3 0 (–0.1–0.2)
Liberia 41.1 (30.2–56.4) 694.7 954.7 37.4 −1.4 (–1.6 to –1.3)
Libya 14.7 (10.3–20.1) 416.7 723.9 73.7 −1.4 (–1.5 to –1.3)
Lithuania 19.5 (15.6–24.5) 353.1 830.5 135.2 3.7 (2.6–4.8)
Luxembourg 9.4 (8.2–10.9) 99.7 90.3 −9.5 −2.7 (–2.9 to –2.6)
Macedonia 10.1 (7.8–12.8) 197.9 316.6 60 −0.2 (–0.3–0)
Madagascar 37.8 (28.5–49.3) 2798.3 4523.8 61.7 −1 (–1.2 to –0.9)
Malawi 46.5 (36.3–57.8) 2900.1 3690.7 27.3 −1.6 (–1.9 to –1.4)
Malaysia 18.3 (14.3–22.7) 1651.5 4782.9 189.6 −0.5 (–0.9 to –0.2)
Maldives 9.8 (8.1–11.7) 20.1 32.6 62.8 −2.9 (–3.1 to –2.6)
Mali 33.1 (24.6–45.5) 2579.3 3266.8 26.7 −2.3 (–2.5 to –2)
Malta 5 (4.4–5.7) 36.7 40.5 10.2 −2 (–2.1 to –1.9)
Marshall Islands 25.3 (14.7–38.4) 7.5 10.2 36.1 −1.5 (–1.6 to –1.5)
Mauritania 27.6 (19.8–37.4) 595.5 602.7 1.2 −2.6 (–2.7 to –2.5)
Mauritius 15.4 (12.5–18.9) 265.3 263.2 −0.8 −3.3 (–3.7 to –3)
Mexico 38.7 (32.7–45.2) 24012.6 46327.6 92.9 −1.3 (–1.4 to –1.1)
Micronesia (Federated States of) 25.3 (13.7–39.8) 20.6 19.7 −4.6 −1.6 (–1.8 to –1.3)
Moldova 48.9 (42.7–56) 3144 2744.8 −12.7 −1.1 (–1.5 to –0.7)
Monaco 9.1 (7–11.2) 6.2 7.4 20.3 −0.3 (–0.4 to –0.2)
Mongolia 72.9 (56.9–91.3) 832.6 1656.5 98.9 0.1 (–0.2–0.4)
Montenegro 5.4 (4.3–6.8) 35.5 49.9 40.4 −0.1 (–0.3–0)
Morocco 16.1 (12.4–19.5) 2732.7 4551.3 66.6 −1 (–1.2 to –0.8)
Mozambique 21.4 (13.1–30.1) 1679.9 2546.6 51.6 −0.7 (–0.9 to –0.5)
Myanmar 38.2 (30.5–47.2) 14646.6 20361.3 39 −1.1 (–1.1 to –1)
Namibia 22.5 (15.5–31.1) 219.8 339 54.2 −1.1 (–1.3 to –0.8)
Nauru 26.7 (15–39.5) 1.8 1.5 −17.8 −1.1 (–1.3 to –1)
Nepal 35.4 (26.3–49.5) 5458.7 7945.4 45.6 −1.2 (–1.3 to –1)
Netherlands 5.4 (4.8–6) 1454.3 1810.4 24.5 −1.6 (–1.9 to –1.3)
New Zealand 3.9 (3.6–4.4) 192.3 297.2 54.6 −1 (–1.1 to –1)
Nicaragua 36.2 (29.6–43.4) 495.7 1623.2 227.4 0.9 (0.7–1)
Niger 36.6 (25.3–52.6) 1650.3 3324.9 101.5 −1.2 (–1.4 to –1.1)
Nigeria 42 (29.3–60.8) 25713.1 40380.6 57 −0.6 (–0.8 to –0.5)
Niue 17.9 (13–23.2) 0.6 0.4 −32.5 −1.4 (–1.5 to –1.4)
North Korea 16 (10.6–20.9) 3621.9 5170.8 42.8 −1 (–1 to –0.9)
Northern Mariana Islands 25.2 (20.8–30) 10.2 12.8 25.3 −2 (–2.2 to –1.9)
Norway 3.9 (3.6–4.4) 367.4 360.3 −1.9 −1.5 (–1.6 to –1.4)
Oman 17.6 (14.6–21.7) 164.6 278.7 69.3 −0.6 (–0.8 to –0.3)
Pakistan 35 (25.2–49.8) 25978.9 44070.2 69.6 −0.6 (–0.8 to –0.5)
Palau 17.5 (10.7–26) 2.5 3.8 55.3 −0.9 (–1 to –0.9)
Palestine 17.1 (14.3–20.4) 206.4 358.7 73.7 −1.1 (–1.2 to –0.9)
Panama 12.1 (9.3–15.4) 212.5 502.9 136.6 −0.2 (–0.4 to –0.1)
Papua New Guinea 10.2 (7.5–13.7) 279.3 660.5 136.4 −0.3 (–0.3 to –0.2)
Paraguay 13 (9.7–17.1) 300.9 749.7 149.1 0.1 (0–0.3)
Peru 21.1 (15.1–28.6) 4065.8 6828.3 67.9 −1.4 (–1.6 to –1.3)
Philippines 17.2 (14.1–21.1) 7843.6 14286.9 82.1 −1.1 (–1.3 to –1)
Poland 14.2 (11.6–17.1) 6450.1 8564.8 32.8 −0.2 (–0.5–0)
Portugal 10.2 (9.4–11) 3658.6 2091.7 −42.8 −3.8 (–4 to –3.7)
Puerto Rico 15.6 (11.9–19.9) 1066.5 1018.8 −4.5 −3 (–3.3 to –2.7)
Qatar 32.3 (23.4–44.3) 36.8 176.7 380.2 −0.2 (–0.4–0.1)
Republic of Congo 37.3 (26.2–48.3) 652 1070.6 64.2 −1.4 (–1.5—1.3)
Romania 31.2 (25.4–37.5) 8646.7 10386.5 20.1 −0.7 (–1 to –0.3)
Russia 22.1 (19–25.5) 16501.9 46101.8 179.4 3.1 (2.3–4)
Rwanda 40.7 (32.1–53.1) 2416.7 2599.1 7.5 −3 (–3.3 to –2.7)
Saint Lucia 15.3 (12.8–18.1) 23.3 32.9 41.3 −2.3 (–2.7 to –1.9)
Samoa 19.4 (14.9–24.9) 25 30.1 20.2 −1.1 (–1.2 to –0.9)
San Marino 12.6 (8.4–18.4) 4.8 8.2 72 −0.5 (–0.6 to –0.4)
Sao Tome and Principe 44 (31.7–58.2) 41.5 49.5 19.1 −1.4 (–1.7 to –1.1)
Saudi Arabia 28.3 (22.9–34.6) 2614.2 3763.1 44 −2.2 (–2.3 to –2.1)
Senegal 29.2 (20.3–40.7) 1489.5 2364.7 58.8 −1.3 (–1.4 to –1.2)
Serbia 9.6 (7.4–12.3) 1516.4 1401.1 −7.6 −1.3 (–1.5 to –1.1)
Seychelles 29 (24.7–33.3) 17.8 33.4 88.1 −0.8 (–1.1 to –0.6)
Sierra Leone 29 (20.4–39.3) 1037.1 1192.3 15 −2.2 (–2.5 to –2)
Singapore 3.3 (2.9–3.6) 205.8 253 23 −3.5 (–3.7 to –3.2)
Slovakia 19.9 (15.2–26.1) 1634.2 1693.7 3.6 −0.8 (–1.1 to –0.6)
Slovenia 14.9 (11.4–20) 781.7 569.3 −27.2 −3 (–3.3 to –2.7)
Solomon Islands 30.8 (24.3–37.7) 70.6 133.1 88.5 −0.8 (–0.8 to –0.7)
Somalia 50.2 (34.7–72.1) 1656.1 3790.4 128.9 −0.5 (–0.6 to –0.4)
South Africa 12.5 (11.1–14.1) 4683.9 5824.4 24.3 −1.9 (–2.3 to –1.4)
South Korea 11.9 (10.6–13.8) 15888.2 10355.6 −34.8 −5.6 (–5.9 to –5.2)
South Sudan 42.1 (28.6–61.7) 1209.5 1706.9 41.1 −0.3 (–0.4 to –0.3)
Spain 8.9 (8.1–9.7) 11524.6 8218 −28.7 −3.3 (–3.5 to –3.2)
Sri Lanka 17.8 (13.6–23.5) 3849.8 4368.8 13.5 −2.7 (–3.2 to –2.1)
Sudan 21.7 (14.1–35.1) 3055.6 4099.7 34.2 −1.2 (–1.3 to –1.1)
Suriname 20.9 (16.8–25.2) 73.3 126.7 72.9 −1.2 (–1.4 to –1)
Sweden 5.5 (5.1–6) 841.8 1068.9 27 −0.3 (–0.4 to –0.2)
Switzerland 6.5 (5.9–7.3) 884.1 1065 20.5 −1.4 (–1.6 to –1.3)
Syria 19.3 (14.3–24.9) 1354.3 2023.6 49.4 −0.9 (–1.2 to –0.7)
Taiwan 19.3 (15.3–24.6) 5646.8 7287.1 29 −2.7 (–3 to –2.5)
Tajikistan 38.8 (31.5–47.5) 927.2 2187.7 136 1 (0.8–1.2)
Tanzania 31.9 (22.5–41.3) 5355.7 8546.7 59.6 −1.1 (–1.4 to –0.8)
Thailand 19.7 (14.9–25.7) 10445.9 19603.4 87.7 −0.9 (–1.1 to –0.8)
Timor-Leste 25.5 (15.8–38) 103.6 210.3 103 −0.4 (–0.5 to –0.2)
Togo 31 (22.4–40.9) 696 1272.1 82.8 −1.7 (–1.9 to –1.5)
Tokelau 16.7 (12.1–22) 0.3 0.2 −31.2 −1.3 (–1.4 to –1.3)
Tonga 23.3 (17.8–29.6) 17.9 19 6.4 −1 (–1.1 to –0.9)
Trinidad and Tobago 10.3 (7.6–13.6) 150 187.5 25 −1.8 (–2 to –1.6)
Tunisia 11.6 (8.3–16.8) 743.8 1366.8 83.8 −0.9 (–1 to –0.9)
Turkey 8.7 (7–10.6) 4950.2 7349.3 48.5 −1.6 (–1.6 to –1.5)
Turkmenistan 52.1 (42.4–64.7) 845.6 2381 181.6 0.9 (0.7–1.2)
Tuvalu 21.9 (14.1–31.8) 2.3 2.3 −2.7 −1.3 (–1.5 to –1.2)
Uganda 33.6 (24.4–41.6) 3010.2 5188.9 72.4 −1.3 (–1.5 to –1.1)
UK 9.5 (9.1–10.1) 4899.2 10031.5 104.8 1.5 (1.1–1.9)
Ukraine 32.4 (27.1–38.9) 7986.6 20141 152.2 3.5 (2.6–4.3)
United Arab Emirates 12.5 (7.5–18.7) 71.4 505.6 607.7 −1.4 (–1.8 to –1)
United States Virgin Islands 19.1 (15.3–22.4) 20.3 33.2 63.6 −0.4 (–0.7 to –0.2)
Uruguay 9.1 (8.2–10) 533 471 −11.6 −1.9 (–2 to –1.8)
USA 13.2 (12.6–13.6) 37385.8 67286.5 80 0.4 (0.3–0.5)
Uzbekistan 53.3 (45.2–62) 4146.9 13042.3 214.5 1 (0.4–1.7)
Vanuatu 25.8 (15.7–37.1) 26.5 49.4 86.8 −1.3 (–1.5 to –1.1)
Venezuela 15.8 (11.6–20.7) 2124.1 4691.7 120.9 −1.1 (–1.3 to –0.9)
Vietnam 25.1 (19.5–31.4) 16676.2 23636.9 41.7 −2.1 (–2.5 to –1.8)
Yemen 20.9 (14.7–30.4) 1546.2 2785.8 80.2 −1.5 (–1.6 to –1.3)
Zambia 60.5 (48.3–75.3) 2373.1 4593 93.5 −1.1 (–1.3 to –0.8)
Zimbabwe 27.3 (17.2–38.9) 1449.6 2065.1 42.5 −0.5 (–0.8 to –0.3)

ASDR: age-standardized death rate; CI: confidence interval; EAPC: estimated annual percentage change; UI: uncertainty interval. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

In addition, the burden of cirrhosis was different between the genders. Globally, the number of deaths, death rate, and ASDR of liver cirrhosis in females is significantly lower than those in males. Among them, the Republic of Moldova had the highest death rate among female patients (67.8 per 100000, 95% UI: 59.3 − 77.5), while Papua New Guinea had the lowest (1.9 per 100000, 95% UI: 1.3 − 2.7). Analysis of the ASDR data, however, found that Egyptian females had the highest (141.4 per 100000, 95% UI: 103.9–191) and Iceland the lowest (1.9 per 100000, 95% UI: 1.6 − 2.2). Analysis of the data for males found that the highest cirrhosis death rate remained in the Republic of Moldova (81.7 per 100000, 95% UI: 70.7 − 93.8), while the lowest became Singapore (5.2 per 100000, 95% UI: 4.7 − 5.8). However, Egyptian males still have the highest ASDR of cirrhosis (124.5 per 100000, 95% UI: 78.7 − 170.3), as do females; Singapore still has the lowest ASDR (3.9 per 100000, 95% UI: 3.5 − 4.4) (Table 4).

Table 4.

Number of liver cirrhosis mortalities, death rate and ASDR by gender in 2019.

Country Female
Male
Mortalities NO. (95% UI) Death rate per 100,000
NO. (95% UI)
ASDR per 100,000
NO. (95% UI)
Mortalities NO. (95% UI) Death rate per 100,000
NO. (95% UI)
ASDR per 100,000
NO. (95% UI)
Global 502944.1 (459202–550914.2) 13 (11.9–14.3) 11.7 (10.7–12.8) 969067.7 (899212.9–1045344.5) 25 (23.2–26.9) 24.8 (23.1–26.8)
Afghanistan 1852.2 (939.1–2848.3) 9.9 (5–15.3) 26.4 (15.6–37.2) 1945.1 (1289.4–2646.8) 9.9 (6.6–13.5) 28.9 (18.7–40)
Albania 116.1 (83.1–154.6) 8.6 (6.1–11.4) 5.3 (3.9–7) 216.6 (152.7–296.9) 15.9 (11.2–21.8) 11.4 (8.1–15.5)
Algeria 1639.3 (1301.1–2005.3) 7.9 (6.3–9.7) 12.1 (9.5–15) 2405.6 (1643.2–3460) 11.3 (7.8–16.3) 15.3 (10.7–21.5)
American Samoa 2.4 (1.9–3.1) 8.8 (6.9–11.1) 10 (7.8–12.6) 4.5 (3.6–5.6) 16.2 (12.7–19.9) 18.7 (14.9–22.8)
Andorra 4.1 (2.8–5.7) 10.1 (7–14) 5.6 (3.9–8) 8.1 (6.1–10.4) 19 (14.2–24.5) 11.6 (8.7–14.9)
Angola 1780.9 (1291.9–2430.4) 11.5 (8.3–15.7) 26 (19.1–35.9) 3884.7 (2936–4956.1) 26.6 (20.1–33.9) 67.9 (54.2–84.2)
Antigua and Barbuda 4.8 (4–5.7) 10.7 (8.9–12.6) 9.2 (7.7–10.9) 8.1 (6.7–9.5) 18.6 (15.6–22) 17 (14.2–20)
Argentina 2426.4 (2093.2–2780.2) 10.5 (9.1–12) 7.9 (6.9–9) 6098.1 (5606.1–6616.4) 27.7 (25.5–30.1) 26 (23.9–28.2)
Armenia 459.6 (384.9–546.6) 29.4 (24.6–35) 19.1 (15.9–22.7) 654.6 (550.2–773) 44.9 (37.7–53) 38.9 (32.7–45.9)
Australia 763.2 (653.9–867.9) 6.1 (5.3–7) 3.6 (3.2–4.1) 1451.6 (1315.2–1582.9) 12 (10.8–13.1) 8.1 (7.4–8.8)
Austria 590.1 (525.4–651.4) 13 (11.6–14.4) 6.4 (5.8–7) 1219.4 (1139–1303) 27.8 (25.9–29.7) 16.6 (15.6–17.7)
Azerbaijan 1321.7 (939.8–1755.4) 25.7 (18.3–34.2) 31.5 (21.5–43.1) 1796.3 (1396.1–2317.4) 34.9 (27.2–45.1) 45.5 (34.7–58.7)
Bahamas 19.7 (15.5–24.5) 10.1 (8–12.6) 9.3 (7.4–11.5) 41.8 (33.4–52.4) 22.9 (18.3–28.7) 21.8 (17.5–27.3)
Bahrain 38.2 (28.6–49.6) 7 (5.2–9.1) 14.8 (11.4–18.7) 100.1 (72–137.6) 11.2 (8–15.3) 20.8 (15.5–27.3)
Bangladesh 8200 (6015.5–12178.3) 10.2 (7.5–15.1) 12.4 (9.2–18.6) 17964.6 (13649.9–22907.3) 22.9 (17.4–29.2) 27.5 (21.1–34.7)
Barbados 13.4 (10.5–16.5) 8.7 (6.8–10.7) 5 (4–6.2) 33.4 (25.9–41.4) 23.2 (18.1–28.8) 15.6 (12.2–19.2)
Belarus 907.7 (688.5–1189.7) 17.9 (13.6–23.5) 10.8 (8.1–14.3) 1326.9 (1004.9–1765.3) 30 (22.7–39.9) 21.6 (16.5–28.7)
Belgium 849.9 (729.6–971.8) 14.7 (12.6–16.8) 7.1 (6.3–7.9) 1255.4 (1134.5–1390.9) 22.3 (20.2–24.8) 13.4 (12.1–14.7)
Belize 19.5 (16.6–22.6) 9.5 (8–11) 13.7 (11.6–15.9) 46 (39.3–53.7) 22.5 (19.2–26.3) 29.9 (25.7–35)
Benin 727.2 (538.6–974.8) 11.3 (8.4–15.1) 25.3 (19.3–33.4) 1215.8 (867.2–1646.2) 19.5 (13.9–26.4) 45 (33.4–59.6)
Bermuda 2 (1.5–2.7) 6 (4.6–8.2) 2.7 (2.1–3.6) 5.9 (4.8–7.1) 19.1 (15.6–23.1) 10.7 (8.8–13)
Bhutan 47.3 (34.3–69.6) 13.1 (9.5–19.2) 17.3 (12.7–25.4) 128.9 (80.3–287.3) 32.8 (20.4–73.2) 41.5 (26.4–91.8)
Bolivia (Plurinational State of) 1287.1 (941.2–1685.1) 21.5 (15.7–28.1) 29 (21.4–37.4) 2031.7 (1448.8–2687.4) 33.8 (24.1–44.7) 48.2 (34.7–63.5)
Bosnia and Herzegovina 180.5 (137–238.4) 10.7 (8.1–14.1) 5.6 (4.2–7.4) 412.8 (316.4–534.6) 25.6 (19.7–33.2) 15.7 (12.1–20.2)
Botswana 131.9 (81.3–194.8) 11.1 (6.8–16.4) 15.7 (9.9–22.8) 285.8 (195.4–398.9) 24.8 (17–34.7) 40.5 (29–56.2)
Brazil 9775 (8853.2–10763) 8.8 (8–9.7) 7.6 (6.8–8.3) 28253.7 (26552.2–30278.5) 26.7 (25.1–28.6) 25.3 (23.7–27.1)
Brunei Darussalam 11.7 (9.6–13.9) 5.6 (4.6–6.7) 7.6 (6.3–8.8) 19.5 (15.5–24.3) 8.5 (6.8–10.6) 10.5 (8.5–12.8)
Bulgaria 616.9 (476.5–772.4) 17.3 (13.4–21.6) 8.9 (6.8–11.3) 2090.1 (1616.9–2621.8) 62.1 (48–77.9) 37.6 (29.2–47.2)
Burkina Faso 1261.5 (509.9–1891) 10.8 (4.4–16.2) 23.6 (8.3–35.9) 1731.6 (787.7–2969.3) 15.7 (7.1–26.9) 37.9 (17.2–64.6)
Burundi 600.7 (318.8–907.3) 10 (5.3–15.1) 26.2 (13.4–39.6) 1305 (702.2–2599.5) 22 (11.8–43.8) 48.3 (25.7–94.4)
Cabo Verde 35.6 (26.7–45.2) 12.7 (9.5–16.2) 14.1 (10.6–17.9) 78.7 (65.1–94.4) 27.7 (22.9–33.3) 38.3 (32.2–45.5)
Cambodia 3654.1 (2889.3–4485) 43.2 (34.2–53.1) 54 (42.5–65.8) 4733.7 (3691.6–5927) 58.1 (45.3–72.7) 83.5 (65.7–102.5)
Cameroon 1405.6 (779.7–2116.6) 9.6 (5.3–14.5) 21 (11.4–31.4) 2725.2 (1783.1–3933.2) 18.8 (12.3–27.1) 39.7 (26.8–56.7)
Canada 2119.4 (1807.7–2472.4) 11.4 (9.7–13.3) 5.9 (5.2–6.7) 3322.6 (2992–3666.4) 18.5 (16.7–20.4) 11 (10–12.1)
Central African Republic 366.1 (222.7–565.5) 13.5 (8.2–20.9) 27.3 (16.7–42) 739.1 (390.7–1293.3) 28.5 (15.1–49.8) 63.6 (37–105.1)
Chad 962.2 (724.6–1256.9) 11.6 (8.8–15.2) 32.3 (24–42) 1923.4 (1433–2551.2) 23.6 (17.6–31.4) 54.8 (40.8–72.5)
Chile 1578.7 (1415.9–1745) 17 (15.3–18.8) 12 (10.8–13.2) 3578.6 (3328–3846.3) 40.1 (37.3–43.1) 32.7 (30.4–35.1)
China 42296.9 (33866.1–52045.4) 6.1 (4.9–7.5) 4.2 (3.4–5.2) 109964.9 (88138.9–136103.1) 15.2 (12.2–18.8) 11.8 (9.6–14.4)
Colombia 1664.1 (1282.2–2153.1) 6.8 (5.2–8.8) 5.7 (4.4–7.3) 2320.4 (1710.1–3058.9) 9.9 (7.3–13.1) 9.6 (7.1–12.7)
Comoros 68.2 (35.5–98.1) 19.1 (9.9–27.4) 26 (13.5–37.4) 93 (57.1–161.7) 26.1 (16–45.3) 40 (24.9–71.2)
Congo 378.1 (248.2–554.2) 14.2 (9.3–20.9) 26 (17.4–37.9) 692.6 (449–920.7) 26.5 (17.2–35.3) 49.9 (33.8–64)
Cook Islands 0.3 (0.2–0.4) 3.7 (2.7–4.9) 2.8 (2–3.6) 1.6 (1.2–2.1) 18.8 (13.6–23.6) 14.3 (10.6–17.8)
Costa Rica 354.3 (273.7–446.3) 14.6 (11.3–18.4) 12.8 (9.8–16) 605.3 (464.7–781.8) 26.5 (20.3–34.2) 25.1 (19.2–32.4)
Croatia 292.8 (228.1–372.9) 13.4 (10.4–17) 6.4 (4.9–8.1) 857.9 (668.7–1082.3) 41.7 (32.5–52.5) 24.4 (18.9–30.8)
Cuba 583.3 (457.5–745.1) 10.2 (8–13.1) 5.9 (4.6–7.5) 1452.5 (1150.7–1809.7) 25.7 (20.4–32) 16.6 (13.2–20.7)
Cyprus 49.8 (40.9–60.1) 7.5 (6.2–9) 5.3 (4.3–6.4) 90.5 (74.6–105.9) 13.9 (11.5–16.3) 10.6 (8.8–12.6)
Czechia 750.4 (601.5–912.2) 13.9 (11.1–16.9) 7.7 (6.2–9.4) 1569.3 (1257.1–1948.7) 30 (24–37.2) 18.5 (14.8–23)
Côte d’Ivoire 1160.6 (728.6–1696.1) 9.2 (5.8–13.4) 21.1 (13.7–30.1) 2787 (1890.4–3821.4) 20.6 (14–28.3) 41.8 (28.6–56.6)
Democratic People’s Republic of Korea 1881.3 (1217.1–2454.2) 14.3 (9.2–18.6) 10.1 (6.5–13.3) 3289.5 (1839.6–4483.5) 25.2 (14.1–34.4) 23.5 (13.5–30.9)
Democratic Republic of the Congo 3754.9 (2755.9–4957.8) 8.6 (6.3–11.3) 17.1 (12.3–23.3) 10637.8 (7061.5–14977.3) 24.2 (16.1–34.1) 56.1 (37.2–78)
Denmark 340.1 (297.3–390.3) 11.7 (10.2–13.4) 6.2 (5.5–7) 614.6 (553–681.4) 21.3 (19.1–23.6) 13 (11.8–14.4)
Djibouti 60.7 (34.5–99.7) 10.8 (6.1–17.7) 22.7 (13.3–36.2) 165.3 (102.8–280.1) 25.9 (16.1–43.8) 46.2 (29–77.7)
Dominica 4 (3.1–5) 11.9 (9.3–14.9) 8.7 (6.8–10.9) 6.9 (5.3–8.6) 19.6 (15.1–24.6) 15.8 (12.2–19.8)
Dominican Republic 1081.3 (805.4–1419.9) 20 (14.9–26.2) 22.6 (17–29.5) 1864 (1277.8–2530.7) 34.1 (23.4–46.3) 41.4 (29.5–55.6)
Ecuador 1522.4 (1160.7–1932.3) 17.2 (13.1–21.9) 20.1 (15.3–25.3) 2382.3 (1820.7–3109) 27.2 (20.8–35.5) 33.4 (25.7–43.5)
Egypt 25635.4 (18067.9–35618.5) 53.7 (37.9–74.7) 141.4 (103.9–191) 37000 (22031.1–50885.4) 72 (42.9–99.1) 124.5 (78.7–170.3)
El Salvador 547.7 (406.9–717.7) 16.5 (12.2–21.6) 15.8 (11.7–20.7) 952.3 (714.6–1242.3) 32.5 (24.4–42.4) 37.6 (28.2–49.1)
Equatorial Guinea 46.2 (27.9–74.3) 7.1 (4.3–11.4) 15.5 (9.5–24.3) 80 (45–134.2) 10.4 (5.9–17.5) 33.4 (20.1–53.3)
Eritrea 606.9 (437.7–843.7) 18.2 (13.1–25.3) 40.4 (29.4–55.2) 965.4 (678.5–1348.7) 28.6 (20.1–40) 68.2 (49.1–93.7)
Estonia 91.1 (69.5–116.7) 13.1 (10–16.8) 8 (6–10.3) 186.1 (138.7–243.4) 30.1 (22.4–39.4) 20.8 (15.6–27.1)
Eswatini 57.6 (31.5–88.8) 9.9 (5.4–15.2) 16 (9.1–24.3) 132 (92.9–181.3) 23.7 (16.7–32.5) 48 (36.2–63.5)
Ethiopia 7259.1 (5543.9–9222.7) 13.6 (10.4–17.3) 36.1 (28.2–44.1) 15513.4 (12404.6–19601.3) 28.6 (22.8–36.1) 67.8 (54.4–84.7)
Fiji 30.8 (23–40) 6.9 (5.1–8.9) 8.1 (6.1–10.5) 55.7 (41.4–72.4) 12.1 (9–15.7) 14.9 (11.4–18.9)
Finland 341.5 (304.8–377.8) 12.2 (10.9–13.5) 6.5 (5.9–7.1) 810.7 (740.8–882.3) 29.7 (27.1–32.3) 18.3 (16.7–19.9)
France 3653.4 (3135.8–4122.4) 10.7 (9.2–12.1) 5.1 (4.6–5.6) 7069 (6419.4–7847) 22 (20–24.4) 13.3 (12.1–14.7)
Gabon 109.4 (71.5–160.2) 12.1 (7.9–17.7) 19.1 (12.1–28.3) 287.8 (201.5–387.3) 34.1 (23.8–45.8) 56.1 (39.9–74.3)
Gambia 127.3 (86.1–188.1) 11.2 (7.5–16.5) 24.3 (15.8–36.4) 230.1 (166.2–306) 20.8 (15–27.7) 43.9 (31.4–58)
Georgia 378.3 (302.4–475) 19.8 (15.8–24.9) 10.6 (8.6–13.1) 1183.7 (982.8–1408.3) 67.4 (56–80.2) 51.9 (43.1–61.6)
Germany 7480.5 (6646–8453.7) 17.5 (15.6–19.8) 7.9 (7.1–8.7) 13011.1 (11909–14350.7) 30.8 (28.2–34) 17.1 (15.7–18.8)
Ghana 2104.4 (1379.9–2851.8) 13 (8.5–17.6) 22.5 (14.8–29.9) 4020.1 (2874.8–5353.1) 26.3 (18.8–35) 50.2 (36.1–66.1)
Greece 480 (403.6–575.4) 9 (7.6–10.8) 3.5 (3–4) 886.4 (797.9–973.8) 17.6 (15.9–19.4) 9.2 (8.4–10)
Greenland 3.8 (2.9–5) 14.4 (11.1–18.7) 11.5 (8.9–14.8) 4.7 (3.5–6.1) 16 (11.7–20.5) 11.3 (8.4–14.3)
Grenada 4.5 (3.8–5.2) 8.9 (7.5–10.3) 7.8 (6.5–9.1) 13.8 (12–16) 26.2 (22.8–30.2) 25 (22–28.8)
Guam 9.6 (7.7–11.7) 11.6 (9.3–14.2) 9.7 (7.7–11.8) 23.4 (19–28.3) 26.6 (21.7–32.2) 25.6 (20.9–31)
Guatemala 1844.7 (1451.8–2318.5) 20.2 (15.9–25.4) 29.6 (23.4–37.1) 3676 (2851.3–4673.6) 42.5 (33–54.1) 66 (51.4–83.8)
Guinea 862 (513.4–1299.7) 13.2 (7.9–19.9) 28.3 (17.3–42.4) 1519.9 (1132.8–1986.2) 24.8 (18.5–32.4) 48.8 (36.4–63.5)
Guinea–Bissau 167.5 (120.3–219.2) 17.2 (12.3–22.4) 38 (27.7–49.2) 281.9 (196.7–380.9) 30.5 (21.3–41.2) 70.1 (50.8–92.1)
Guyana 57.6 (44.4–73.4) 14.8 (11.4–18.9) 16.9 (13.1–21.4) 193.2 (148–247.9) 50.7 (38.8–65) 59.1 (45.8–75.2)
Haiti 789.9 (364.1–1218.6) 12.4 (5.7–19.1) 20 (9.5–30.4) 1361.5 (722.3–1965) 22.6 (12–32.7) 37.5 (20.2–53.6)
Honduras 1464.1 (926.3–2095.5) 29.1 (18.4–41.6) 46.7 (29.6–66) 1488.1 (981.2–2066.1) 31.1 (20.5–43.2) 51.7 (33.8–71.6)
Hungary 1045 (861.2–1264.5) 20.6 (17–25) 11.1 (9.1–13.5) 2465.5 (2021.1–3005.1) 53.5 (43.9–65.2) 33.1 (27.1–40.1)
Iceland 5 (4.2–5.9) 3 (2.5–3.4) 1.9 (1.6–2.2) 11.9 (10.4–13.6) 6.8 (6–7.8) 4.8 (4.2–5.4)
India 80525 (60942.9–106127.8) 11.9 (9–15.7) 13.7 (10.4–18) 189511.8 (151610–232564.6) 26.6 (21.3–32.6) 31.3 (25.1–38.4)
Indonesia 36755.7 (29384.3–44683.1) 28.6 (22.9–34.8) 36.3 (29.4–43.4) 51914.5 (41228.9–64969.4) 39.7 (31.5–49.6) 51.5 (41.7–62.5)
Iran (Islamic Republic of) 2593.5 (2300.6–2993.7) 6.3 (5.5–7.2) 7.9 (6.9–9.2) 4238.3 (3713.1–4791) 9.9 (8.7–11.2) 11.9 (10.4–13.4)
Iraq 1021.5 (795.6–1295.2) 5 (3.9–6.3) 8.8 (7–10.8) 1698.6 (1284.4–2127.1) 7.9 (6–9.9) 15 (11.5–18.5)
Ireland 148.6 (126.7–169.8) 6 (5.1–6.8) 4 (3.4–4.5) 239.9 (211.9–268.6) 9.9 (8.7–11.1) 7.2 (6.3–8)
Israel 331.6 (277.8–400.3) 7.1 (5.9–8.6) 4.9 (4.2–5.8) 424.4 (375.8–488.5) 9.2 (8.1–10.5) 8.2 (7.3–9.4)
Italy 5470.4 (4631.7–5986.9) 17.7 (15–19.3) 6.1 (5.4–6.6) 6980.1 (6486.2–7472.3) 23.8 (22.1–25.5) 11.8 (11.1–12.6)
Jamaica 67.5 (50.9–85.7) 4.8 (3.6–6.1) 4.2 (3.1–5.3) 117.6 (87.9–153.8) 8.4 (6.3–11) 8.2 (6.2–10.7)
Japan 11436 (8664.8–13656) 17.5 (13.2–20.8) 4.7 (3.9–5.2) 14812.4 (13505.9–16342.6) 23.8 (21.7–26.2) 10.7 (10–11.5)
Jordan 255.5 (196.2–330) 4.7 (3.6–6.1) 9.9 (7.7–12.7) 388.5 (289.4–504.1) 6.3 (4.7–8.1) 12 (8.7–15.5)
Kazakhstan 2729.7 (2321.8–3192.1) 28.8 (24.5–33.7) 27 (23–31.4) 3975.3 (3266.2–5180.8) 44.6 (36.7–58.2) 51.7 (43–65.9)
Kenya 4867.1 (2810.8–7689.4) 19.3 (11.2–30.6) 42.7 (25.2–65.6) 8227.8 (5757.4–12340.4) 32.8 (23–49.2) 73.9 (53–110.1)
Kiribati 9.3 (5.4–14) 15.3 (8.9–23.1) 24.1 (16.1–33.8) 17.8 (7.8–30.6) 30.6 (13.3–52.6) 46.4 (21.9–76.5)
Kuwait 49.9 (40.5–60.2) 2.4 (2–2.9) 5.2 (4.2–6.4) 153.9 (119.1–194.4) 6.5 (5–8.2) 9.8 (7.6–12.1)
Kyrgyzstan 715.2 (624.6–817.2) 21.7 (18.9–24.7) 26.2 (22.9–29.8) 1427.9 (1251.6–1626.7) 44.2 (38.7–50.3) 58 (50.7–65.9)
Lao People’s Democratic Republic 392.4 (283.1–515.8) 11 (8–14.5) 17.2 (12.6–22.5) 880.4 (590.8–1244.3) 24.5 (16.4–34.6) 36.2 (24.6–51.3)
Latvia 153.3 (114.3–204.7) 14.8 (11.1–19.8) 8.7 (6.4–11.7) 234.6 (174.6–303.6) 26.6 (19.8–34.4) 18.2 (13.6–23.6)
Lebanon 258.8 (175–417.6) 9.8 (6.7–15.9) 9.2 (6.2–14.7) 337.6 (139.9–537.2) 13.3 (5.5–21.1) 14.6 (6.1–23.2)
Lesotho 132.5 (65.4–199.8) 12.5 (6.2–18.9) 17.4 (8.7–25.9) 262.5 (167.3–380.9) 25.4 (16.2–36.9) 44.1 (29.6–63.1)
Liberia 339.5 (233.9–479.1) 14.3 (9.8–20.1) 31.5 (22.6–43.2) 615.2 (399.8–905.5) 25.5 (16.6–37.5) 50.1 (33.7–70.8)
Libya 289.9 (214.3–375.2) 8.9 (6.6–11.5) 12.2 (8.8–15.9) 434 (256.7–633.9) 12.5 (7.4–18.2) 17 (10.7–25)
Lithuania 305.8 (242.8–385.3) 20.3 (16.1–25.6) 12.3 (9.8–15.6) 524.7 (415.3–652.4) 40.7 (32.2–50.6) 28.3 (22.4–35.1)
Luxembourg 31.5 (26.6–37.1) 10.3 (8.6–12.1) 6 (5.1–7) 58.8 (50.5–68.5) 18.9 (16.2–22) 13 (11.2–15.1)
Madagascar 1742.1 (1223.6–2324.3) 13.1 (9.2–17.4) 29.9 (21.3–40.1) 2781.7 (1979.7–3824.7) 20.8 (14.8–28.7) 46.1 (34.1–61.9)
Malawi 1148.8 (746.7–1515.4) 12.1 (7.9–16) 28.3 (17.8–37.5) 2541.9 (1925.4–3251) 28.3 (21.5–36.2) 68.7 (52.3–88.1)
Malaysia 1535.6 (1144.1–1943.6) 10.2 (7.6–12.9) 12.6 (9.4–15.9) 3247.3 (2485.4–4143.7) 20.1 (15.3–25.6) 23.7 (18–30.3)
Maldives 9.4 (7.6–11.5) 4.8 (3.8–5.8) 7.4 (5.9–9) 23.2 (18.8–28) 7.7 (6.3–9.3) 11.5 (9.4–13.9)
Mali 1251.4 (756.6–1911.1) 11.3 (6.9–17.3) 27 (16.1–40.4) 2015.4 (1311.5–3162.1) 18.5 (12–29) 39 (25.2–60.3)
Malta 13.5 (11.2–16) 6.1 (5.1–7.3) 3.1 (2.6–3.6) 27 (23.1–30.8) 12.3 (10.5–14.1) 7.1 (6.2–8.1)
Marshall Islands 3 (1.4–4.9) 10.7 (5.2–17.7) 16.6 (8.4–26.5) 7.2 (4–11.3) 24.7 (13.8–38.9) 33.5 (19.6–51.4)
Mauritania 241.8 (176.5–325.6) 11.8 (8.7–16) 23.1 (17–30.9) 360.8 (221.6–570.8) 18.3 (11.2–28.9) 32.4 (20.8–49.6)
Mauritius 60 (47.6–74.1) 9.3 (7.4–11.5) 6.6 (5.2–8.2) 203.2 (163–251.4) 32.3 (25.9–39.9) 24.9 (20–30.6)
Mexico 12967.1 (10634.4–15799.9) 20.3 (16.7–24.8) 21 (17.3–25.5) 33360.5 (26755.3–40980.8) 54.6 (43.8–67.1) 58.6 (47.1–71.7)
Micronesia (Federated States of) 5.8 (3–9.5) 11.5 (6–18.9) 15.8 (8.4–25.1) 13.9 (6.7–23.4) 26.8 (12.9–45) 35.3 (18.4–57.7)
Monaco 3 (2.2–3.8) 15.7 (11.2–19.6) 6.3 (4.5–8) 4.4 (3.5–5.4) 24 (19.1–29.8) 12.1 (9.6–15)
Mongolia 736.2 (551.5–953.6) 42.9 (32.1–55.6) 62.7 (47.2–79.6) 920.3 (718.7–1179.7) 55.1 (43–70.6) 83.6 (66.1–104.2)
Montenegro 11.8 (9.1–14.7) 3.7 (2.9–4.7) 2.4 (1.9–2.9) 38.2 (29.5–49.2) 12.4 (9.6–16.1) 8.7 (6.7–11.2)
Morocco 1852.4 (1428.1–2332.6) 10.4 (8–13) 13.1 (10.1–16.3) 2698.9 (1981.5–3388.9) 14.9 (11–18.7) 19.2 (14–24.1)
Mozambique 954.4 (340.1–1501.4) 6.2 (2.2–9.8) 16 (5.4–25.6) 1592.2 (893.6–2612.2) 11.2 (6.3–18.4) 28.2 (16.2–46.4)
Myanmar 5044.2 (3917.1–6385.8) 17.8 (13.8–22.5) 17.9 (14.1–22.4) 15317.1 (12051.9–19095.9) 58.2 (45.8–72.6) 62.4 (49.8–77.5)
Namibia 105.3 (53.9–169.3) 8.5 (4.3–13.7) 12.6 (6.5–19.7) 233.8 (161.1–315.1) 20.1 (13.8–27.1) 35.6 (24.9–47.8)
Nauru 0.4 (0.2–0.6) 7.5 (3.7–12.4) 15.5 (8.4–23.8) 1.1 (0.5–1.8) 21.1 (9.9–34.3) 38.6 (20.4–59.8)
Nepal 2903 (2171.1–3883.5) 18.2 (13.6–24.4) 25.2 (19–33.4) 5042.4 (3639.4–7743.6) 34.8 (25.1–53.4) 46.8 (33.8–72.5)
Netherlands 810.7 (674.1–960) 9.4 (7.8–11.1) 4.1 (3.5–4.7) 999.7 (886.7–1123.1) 11.7 (10.4–13.2) 6.9 (6.1–7.7)
New Zealand 112 (93.8–132.2) 4.8 (4.1–5.7) 2.6 (2.2–3.1) 185.2 (165–208.1) 8.5 (7.5–9.5) 5.4 (4.8–6)
Nicaragua 456.5 (376.9–537.9) 13.8 (11.4–16.3) 19.6 (16.2–22.9) 1166.7 (924.3–1446.6) 36.3 (28.8–45) 56.3 (44.9–68.7)
Niger 1275.3 (819.3–1794.3) 10.9 (7–15.3) 28.7 (17.6–40.3) 2049.6 (1230.1–3263.4) 17.7 (10.6–28.2) 45 (26.7–69.9)
Nigeria 13675.1 (8544.8–21010.4) 12.3 (7.7–18.8) 28.6 (18.8–42.1) 26705.5 (16876.8–42734) 25.9 (16.3–41.4) 57.3 (36.5–89.7)
Niue 0.1 (0.1–0.2) 14.1 (9–20) 10.3 (6.6–14.7) 0.3 (0.2–0.3) 30.4 (22.8–38.1) 26.2 (19.9–32.9)
North Macedonia 84.6 (63.9–108.6) 8 (6–10.3) 5.3 (4.1–6.8) 232.1 (176.8–300.6) 21.2 (16.2–27.5) 15 (11.6–19.3)
Northern Mariana Islands 3.8 (2.9–4.7) 18.3 (14.3–23) 16.3 (13.1–20.4) 9 (7.3–10.8) 41.2 (33.3–49.2) 33.6 (27.4–39.8)
Norway 143.3 (124.1–172.6) 5.4 (4.7–6.5) 2.7 (2.4–3.2) 217 (195.7–245.8) 8 (7.3–9.1) 5.1 (4.6–5.8)
Oman 90.5 (69.2–116.5) 5.6 (4.2–7.2) 13.6 (10.8–16.8) 188.2 (134.7–282.3) 6.4 (4.6–9.6) 21.5 (17.1–27.6)
Pakistan 24521.1 (17965.1–34663.4) 22.5 (16.4–31.7) 41.8 (30.3–59.6) 19549.1 (12206.9–31453.5) 17 (10.6–27.4) 28.4 (17.3–46.7)
Palau 0.8 (0.5–1.3) 10.3 (5.6–15.9) 8.5 (4.7–13) 3 (1.7–4.5) 30.2 (17.7–45.9) 25.8 (15.9–38.3)
Palestine 167.3 (135.7–200.6) 6.9 (5.6–8.3) 15.2 (12.2–18.3) 191.3 (155.9–229.6) 7.6 (6.2–9.1) 19.7 (16–23.5)
Panama 191.9 (148.5–241.1) 9.3 (7.2–11.7) 8.9 (6.8–11.1) 311 (236.4–402.6) 14.8 (11.3–19.2) 15.4 (11.7–19.9)
Papua New Guinea 88.3 (60–127.7) 1.9 (1.3–2.7) 2.9 (1.9–4.4) 572.2 (411–777.3) 11.2 (8.1–15.2) 17 (12.5–22.9)
Paraguay 162.1 (121.1–212.4) 4.7 (3.5–6.2) 5.5 (4.1–7.2) 587.6 (432.5–775.6) 16.8 (12.3–22.1) 21 (15.4–27.7)
Peru 2466.7 (1745.9–3349.6) 14.5 (10.3–19.7) 14.8 (10.5–20.1) 4361.6 (3047.4–6070.3) 25.6 (17.9–35.6) 27.9 (19.5–38.7)
Philippines 3953.8 (2999.3–5060.6) 7.2 (5.4–9.2) 9.9 (7.5–12.5) 10333.1 (7837–13384.3) 18.2 (13.8–23.5) 25.2 (19.2–32.5)
Poland 2503.2 (1959.6–3121.4) 12.6 (9.9–15.7) 7.3 (5.7–9.2) 6061.6 (4773–7722.6) 32.6 (25.6–41.5) 21.9 (17.3–27.8)
Portugal 591.9 (508.9–668.9) 10.6 (9.1–12) 4.8 (4.3–5.3) 1499.7 (1382.5–1626.3) 29.6 (27.3–32.1) 16.7 (15.3–18)
Puerto Rico 337.6 (259.1–432.8) 18.3 (14–23.4) 8.3 (6.4–10.6) 681.2 (516.9–868.3) 40.7 (30.9–51.9) 24.2 (18.3–31.1)
Qatar 37.1 (25.7–50.9) 5.1 (3.5–7) 35.1 (25.7–46) 139.6 (94.1–199.7) 6.5 (4.4–9.3) 31.1 (21.9–44.4)
Republic of Korea 2929.9 (2415.7–3714.9) 11.1 (9.1–14.1) 6 (5–7.5) 7425.7 (6543.8–8505.1) 27.5 (24.3–31.5) 18.2 (16.1–21.4)
Republic of Moldova 1308 (1144.8–1495) 67.8 (59.3–77.5) 40.1 (35–45.9) 1436.8 (1244–1649.5) 81.7 (70.7–93.8) 59.5 (51.6–68.2)
Romania 3805.7 (3188.4–4593.4) 38.5 (32.3–46.5) 19.8 (16.4–24.1) 6580.8 (5352.1–7948.7) 70.3 (57.2–84.9) 44 (35.7–53)
Russian Federation 19070.5 (15589.7–23143.3) 24.3 (19.9–29.5) 15.9 (12.9–19.4) 27031.2 (21856–32860.8) 39.6 (32–48.1) 30 (24.3–36.4)
Rwanda 954 (671.2–1233.4) 14.6 (10.3–18.9) 28 (18.9–35.7) 1645.2 (1183.9–2426.3) 26.7 (19.2–39.3) 57.7 (42.9–82.3)
Saint Kitts and Nevis 2.6 (1.9–3.4) 8.6 (6.5–11.3) 7.8 (5.9–10.1) 9.9 (7.5–12.2) 33.2 (25.1–41) 29.1 (22.6–35.4)
Saint Lucia 11.4 (9.4–13.7) 13 (10.7–15.6) 10.1 (8.3–12.1) 21.5 (17.6–25.7) 24.7 (20.3–29.6) 20.8 (17.2–24.9)
Saint Vincent and the Grenadines 3.8 (3.1–4.6) 6.9 (5.7–8.2) 5.9 (4.8–7) 15.1 (12.3–18) 26.1 (21.2–31.1) 21.8 (17.8–25.9)
Samoa 9.6 (6.4–13.5) 9.4 (6.3–13.1) 12.8 (8.7–17.9) 20.5 (15.1–27) 18.8 (13.9–24.8) 26 (19.7–34)
San Marino 3.7 (2.4–5.4) 21.6 (14.2–31.6) 10.1 (6.6–15.1) 4.5 (3–6.4) 28.3 (18.7–40.1) 15.6 (10.3–22.6)
Sao Tome and Principe 13.4 (7.7–19.1) 13.1 (7.6–18.6) 24.5 (13.7–34.7) 36.1 (27.2–47.5) 35 (26.4–46.1) 64.7 (48.9–82.7)
Saudi Arabia 1291.1 (987–1691.2) 8.7 (6.6–11.4) 24.4 (18.5–31.6) 2472 (1818.8–3080.6) 11.9 (8.7–14.8) 30.9 (24.2–37.6)
Senegal 815.9 (490.1–1227.9) 10.8 (6.5–16.3) 20.4 (12.1–30.9) 1548.8 (1022.7–2453.2) 20.4 (13.5–32.3) 38.6 (25.9–60.1)
Serbia 362.7 (278.1–472) 8.2 (6.3–10.7) 4.5 (3.4–5.8) 1038.4 (783.4–1345.1) 23.9 (18.1–31) 15.3 (11.6–19.9)
Seychelles 8.7 (7.1–10.3) 17.9 (14.7–21.4) 15.5 (12.8–18.5) 24.7 (20–29.6) 46 (37.2–55) 41.1 (33.5–48.7)
Sierra Leone 452.1 (236.1–708.7) 10.8 (5.6–16.9) 22.6 (10.9–35.7) 740.2 (498.3–1046.2) 18 (12.1–25.5) 35.1 (23.7–49.5)
Singapore 102.1 (87.4–115.1) 3.7 (3.2–4.2) 2.6 (2.2–2.9) 150.9 (135.7–167.7) 5.2 (4.7–5.8) 3.9 (3.5–4.4)
Slovakia 492.4 (371.3–634.8) 17.7 (13.3–22.8) 10.6 (8–13.9) 1201.3 (910–1593.3) 45.3 (34.3–60) 30.4 (23.1–40.2)
Slovenia 151.3 (113.9–204.7) 14.5 (10.9–19.6) 7.3 (5.5–10) 418 (316.8–557) 40.6 (30.8–54.1) 23.4 (17.7–31.1)
Solomon Islands 39 (29.2–50.7) 12.1 (9.1–15.8) 19.5 (15.2–24.7) 94.1 (72.5–118.8) 28.2 (21.7–35.5) 41.8 (32.5–52.7)
Somalia 1375.8 (850.1–2125.6) 13.8 (8.5–21.3) 35.5 (22.2–54.5) 2414.6 (1555.2–3522.6) 23.3 (15–34) 69.1 (45.8–97.6)
South Africa 2002.9 (1699.1–2330.4) 7.1 (6–8.2) 7.7 (6.6–9) 3821.6 (3347.6–4414.6) 14 (12.3–16.2) 18.7 (16.5–21.5)
South Sudan 544.3 (351.7–824.4) 11.8 (7.6–17.8) 29.5 (20.1–43.5) 1162.6 (744–1833.4) 24.9 (16–39.3) 53.9 (35.6–83.1)
Spain 2983.5 (2470.9–3513.4) 12.7 (10.5–15) 5 (4.3–5.7) 5234.5 (4786.7–5787.1) 23.2 (21.2–25.7) 13.2 (12–14.4)
Sri Lanka 1038.8 (780.9–1353.2) 9.2 (6.9–12) 7.9 (5.9–10.3) 3330.1 (2446.3–4498.9) 31.5 (23.2–42.6) 29.5 (22–39.2)
Sudan 1549.9 (1001.3–2416.9) 7.7 (5–12) 17.5 (10.9–28.8) 2549.7 (1417.5–4150.2) 12.3 (6.9–20.1) 25.4 (14.1–42.8)
Suriname 42.6 (34.3–52.4) 14.6 (11.8–18) 13.4 (10.8–16.4) 84.1 (65.9–103.1) 29.5 (23.1–36.2) 29.4 (23.1–36.1)
Sweden 398.4 (348.4–448.9) 7.8 (6.8–8.8) 3.7 (3.3–4.1) 670.4 (612.9–732.8) 13.1 (11.9–14.3) 7.5 (6.9–8.2)
Switzerland 410.8 (345.1–507.1) 9.3 (7.8–11.5) 4.4 (3.8–5.2) 654.3 (586.4–736.8) 15 (13.4–16.9) 8.7 (7.9–9.7)
Syrian Arab Republic 848.9 (640.8–1107.8) 11.4 (8.6–14.9) 18.9 (14.9–23.7) 1174.7 (742.6–1603.8) 16.6 (10.5–22.7) 20.5 (13.3–27.4)
Taiwan (Province of China) 2324.2 (1803–2931.1) 19.5 (15.1–24.6) 10.9 (8.4–13.8) 4962.9 (3871.1–6399.5) 42.4 (33–54.6) 28.2 (22.1–36.2)
Tajikistan 909.6 (727–1131.4) 19.4 (15.5–24.1) 33.1 (26.5–40.3) 1278.1 (1024.7–1585.2) 26.6 (21.4–33) 44.8 (35.9–56.1)
Thailand 5812.3 (4327.7–7720) 16.2 (12.1–21.5) 10.6 (7.9–14.1) 13791.1 (10126.9–18214.7) 40.3 (29.6–53.2) 29.5 (21.8–38.7)
Timor-Leste 67.4 (44–95.9) 10.2 (6.7–14.5) 17 (11.4–24.1) 142.9 (75.9–234.4) 21.2 (11.2–34.7) 33.7 (18.6–55.4)
Togo 484.5 (301.1–690) 12 (7.4–17.1) 22.4 (13.1–32.1) 787.6 (524.7–1127.4) 20.3 (13.5–29.1) 41.3 (28.1–58.3)
Tokelau 0.1 (0.1–0.1) 12.8 (8–18.7) 13.6 (8.7–19.9) 0.1 (0.1–0.2) 17.7 (13.1–23.6) 19.6 (14.6–26.1)
Tonga 6.3 (4.6–8.4) 12.2 (8.9–16.3) 14.2 (10.4–19) 12.7 (9.7–16.4) 25 (19–32.1) 33.3 (25.6–42.4)
Trinidad and Tobago 56.2 (41.4–75.1) 8.1 (6–10.9) 6.1 (4.5–8.1) 131.3 (95.4–176.8) 18.9 (13.7–25.4) 14.8 (10.8–19.9)
Tunisia 545.2 (385.7–775.4) 9.4 (6.6–13.3) 9 (6.4–12.8) 821.6 (556.2–1233.7) 14.3 (9.7–21.4) 14.5 (10–21.3)
Turkey 3226.5 (2554.6–3970.7) 8 (6.3–9.9) 7.1 (5.7–8.8) 4122.8 (3253.7–5179.5) 10 (7.9–12.6) 10.3 (8.1–12.9)
Turkmenistan 803.6 (645–1010.5) 32.3 (25.9–40.6) 34.6 (27.9–43.6) 1577.4 (1275–1964.2) 60.8 (49.1–75.7) 71.1 (57.8–87.7)
Tuvalu 0.7 (0.4–1.1) 12.8 (7.5–19.4) 13.9 (8.3–20.9) 1.5 (1–2.3) 25 (16–36.8) 29.9 (19.8–43.5)
Uganda 1840.3 (1036.1–2466.8) 8.8 (5–11.8) 23 (13–30.3) 3348.6 (2285.2–4550.7) 16.6 (11.3–22.5) 46.9 (31.3–62.9)
Ukraine 6299.8 (4832–8161.8) 26.5 (20.3–34.4) 17.9 (13.5–23.2) 13841.2 (10878.7–17099.7) 68.2 (53.6–84.3) 50.1 (39.5–61.7)
United Arab Emirates 85.6 (51.9–125.9) 3.4 (2–5) 10.1 (5.9–15.7) 420.1 (252.3–622.9) 6.3 (3.8–9.3) 13.4 (7.6–20)
United Kingdom 3964.7 (3653.6–4328.6) 11.7 (10.8–12.7) 7 (6.5–7.5) 6066.8 (5765–6409.3) 18.2 (17.3–19.3) 12.2 (11.7–12.9)
United Republic of Tanzania 3072 (1700.8–4411.3) 10.5 (5.8–15.1) 23 (12–33.7) 5474.6 (3933.7–7571.9) 19.8 (14.3–27.4) 41.5 (29.3–57.1)
United States of America 26066.1 (24303.2–27545.6) 15.6 (14.6–16.5) 9.4 (8.9–9.9) 41220.4 (39347.1–42657) 25.6 (24.4–26.4) 17.3 (16.5–17.9)
United States Virgin Islands 9.3 (7.3–11.3) 17.1 (13.3–20.6) 9.4 (7.3–11.3) 23.8 (18.3–28.4) 48.3 (37.1–57.7) 30.7 (23.6–36.8)
Uruguay 142.5 (118.7–166.7) 8 (6.6–9.3) 4.3 (3.6–5) 328.5 (295.1–365.4) 19.9 (17.9–22.2) 15 (13.5–16.6)
Uzbekistan 5509.3 (4623.5–6541.2) 32.7 (27.4–38.8) 43.9 (37.3–51.2) 7533 (6291.9–8925.9) 44.8 (37.4–53.1) 64 (54.1–75.1)
Vanuatu 13.1 (7.7–19.6) 9 (5.3–13.5) 15 (9.1–21.9) 36.3 (21.5–53.5) 24.3 (14.4–35.8) 36 (21.4–53.2)
Venezuela (Bolivarian Republic of) 1065.8 (755–1415) 7.5 (5.3–9.9) 6.9 (4.9–9.2) 3626 (2653.4–4782.9) 26.3 (19.3–34.7) 25.6 (18.8–33.6)
Viet Nam 5686.6 (4209.6–7370.6) 11.7 (8.7–15.2) 11.5 (8.5–14.9) 17950.3 (13796.6–22803.6) 37.6 (28.9–47.8) 42.4 (32.9–52.3)
Yemen 1182.9 (803.7–1668.4) 7.6 (5.2–10.7) 17.5 (11.7–25.8) 1602.9 (1035.3–2353.6) 10.1 (6.5–14.8) 24.4 (15.8–37)
Zambia 1401.7 (1037.2–1848.6) 15.2 (11.2–20) 38 (29.1–50.4) 3191.3 (2460.2–4152.9) 35.4 (27.3–46.1) 84.6 (67.7–105.1)
Zimbabwe 685.1 (232.8–1142.5) 8.8 (3–14.6) 17 (5.8–28.4) 1380 (885.2–2016) 19.1 (12.3–28) 41.2 (27.2–59.6)

ASDR: age-standardized death rate; UI: uncertainty interval. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

We performed a stratified cluster analysis for each country based on EAPC incidence and death. A total of 173 countries and territories, including Tunisia, the Syrian Arab Republic, and Egypt, were designated to the ‘remained stable or minor decrease’ group. 10 countries and territories, including Spain, Mauritius, and Taiwan (Province of China), were classified as a ‘significant decrease’ group. 6 countries including Lithuania, Belarus, and Armenia are classified as the ‘significant increase’ group. 15 countries and territories, including Kuwait, Azerbaijan, and India, are divided into the ‘minor increase’ group (Figure 3 and Supplementary Table 1).

Figure 3.

Figure 3.

Cluster analysis: Estimated annual percent change data combining incidence and deaths. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

3.2. Percentage change of cirrhosis caused by different causes

The percentage of the five causes of cirrhosis has changed greatly from 1990 to 2019. Globally, the top three causes of cirrhosis in 1990 were hepatitis B (28.2%), other causes (24.3%), and hepatitis C (23.2%). However, in 2019, the top three causes changed to hepatitis C (26.9%), hepatitis B (25.4%), and alcohol use (21.3%). Notably, the proportion of cirrhosis due to NAFLD also increased significantly (Figure 4).

Figure 4.

Figure 4.

Contribution of hepatitis B, hepatitis C, NAFLD, alcohol use, and other causes to cirrhosis cases (in both genders), ­globally and regionally, in 1990 and 2019: A. The proportion of cirrhosis caused by various causes in 1990; B. The proportion of cirrhosis caused by various causes in 2019. NAFLD, Non-alcoholic fatty liver disease. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

From the perspective of different causes, liver cirrhosis caused by hepatitis B mostly occurs in East Asia, whether in 1990 (37.7%) or 2019 (30.9%). Liver cirrhosis caused by hepatitis C mostly occurred in North America and high–income North America, accounting for 41.1% in 1990 and increasing to 50.8% in 2019. The proportion of cirrhosis due to NAFLD was highest in Central and Latin America, which increased from 12.8% in 1990 to 16.2% in 2019. Interestingly, we found that the region with the largest proportion of cirrhosis due to alcohol use changed from Western Europe in 1990 (38.3%) to Central Europe in 2019 (43.1%). The region with the highest proportion of cirrhosis that could not be classified into the above four causes changed from South Asia (53.4%) in 1990 to Western Sub–Saharan Africa (47.8%) in 2019.

3.3. Summary exposure value (SEV) and proportion of DALYs and deaths attributable to alcohol or drug use in different regions

Further, we analysed how the SEV of alcohol consumption and drug use varied across regions of the globe. As shown in Figure 5 and Supplementary Table 2, there has been a significant 14% increase in alcohol use globally; The SEV of alcohol use in Western Europe and Oceania was consistently high, exceeding 15 since 1990. Notably, the largest increase in SEV attributable to alcohol use was observed in Southeast Asia, reaching 104.1%. The global SEV change in drug use was stable, increasing by only 2.7%. However, the 101% increase in SEV attributable to drug use in North America should be of concern.

Figure 5.

Figure 5.

Summary exposure value changes of alcohol and drug use in 46 GBD regions from 1990 to 2019: A. Changes in SEV for alcohol use; B. Changes in SEV for alcohol use. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

In addition, we focused on the effects of alcohol use and drug use on cirrhosis. Globally, 49.3% of DALYs and 48.4% of deaths can be attributed to alcohol use. By region, the effects of alcohol use were highest in Western Europe (75.6% DALYs and 73% deaths) and lowest in the Middle East & North Africa–WB (11.8% DALYs and 10.4% deaths) (Figure 6(A)).

Figure 6.

Figure 6.

Proportion of DALYs and deaths from cirrhosis due to alcohol use and drug use in 46 GBD regions in 2019: A. Proportion of DALYs and death in cirrhosis due to alcohol use; B. Proportion of DALYs and death in cirrhosis due to drug use. DALYs, Disability Adjusted Life Year; GBD, Global Burden of Disease, Injury, and Risk Factors Study. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

Drug use has a smaller effect on cirrhosis than alcohol use. Globally, 14.9% of DALYs and 14.1% of deaths were attributed to drug use. The effect of drug use was greatest in North America and high–income North America (41.6% of DALYs and 39.4% of deaths), whereas the effect was smallest in Western Sub–Saharan Africa (0.1% of DALYs and deaths) (Figure 6(B)).

3.4. Correlation analysis of EAPC with ASR and HDI

Further, we analysed the correlation between EAPC, ASR, and HDI. In 1990, EAPC showed a significant negative correlation with ASIR (ρ = −0.29, p < 0.001) and ASDR (ρ = −0.17, p = 0.0137) (Figure 7(A)). Interestingly, as of 2019, there is a significant positive correlation between EAPC and ASIR (ρ = 0.34, p < 0.001) and ASDR (ρ = 0.22, p = 0.0018) (Figure 7(B)). As a result, the pattern of cirrhosis has changed considerably over the past 30 years. Surprisingly, there was no significant correlation between HDI and EAPC (p > 0.05) (Figure 7(C)).

Figure 7.

Figure 7.

Correlation of EAPC with cirrhosis ASR and HDI: A. Correlation of EAPC with cirrhosis ASIR and ASDR in 1990. B. Correlation of EAPC with 2019 cirrhosis ASIR and ASDR. C. Correlation of EAPC with 2019 HDI. The circles in the figure represent countries, and the size of the circles represents the number of cases of cirrhosis. ρ and P values were obtained from Pearson correlation coefficient analysis. ASR, age–standardized rate; ASIR, age–standardized Incidence rate; ASDR, age–standardized death rate; EAPC, estimated annual percentage change; HDI, human development index. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

Therefore, we found a significant negative association of EAPC with baseline ASR in 1990 but showed a significant positive association in 2019. The reasons may be related to two factors, first, the lower the baseline of ASR, the more significant the changes. Second, cirrhosis has insufficient priority over other public problems, so these countries with lower ASR will invest fewer resources in it. While in 2019, countries with higher ASR were more likely to increase liver cirrhosis. This result may be attributed to the aging population, with a large elderly population increasing the incidence of cirrhosis.

3.5. Changes in ASR trends in cirrhosis by SDI–based region and country

As shown in Figure 8, we studied the variation trend of ASR based on SDI in different regions and countries. The changes in North Africa and the Middle East, South Asia, and southern Latin America are consistent with the expected trends. However, in many areas of the mid–posterior region of SDI, the phase ASR fluctuates greatly. For example, ASR in central Asia was significantly higher than expected, and the fluctuation increased. Although the overall ASR of the high–income Asia Pacific region is higher than expected the fluctuation decreases (Figure 8(A)). At the national level, with some exceptions, the ASR of liver cirrhosis was negatively associated with SDI in various countries in 2019 (Figure 8(B)).

Figure 8.

Figure 8.

ASR trends in cirrhosis by socio–demographic index, 1990–2019: A. 21 GBD regions; B. 204 countries and territories. Expected values for sociodemographic indices and disease incidence based on all sites are shown as black lines. ASR, age–standardized rate; GBD, Global Burden of Diseases, Injuries, and Risk Factors Study. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

3.6. Prediction of global cirrhosis incidence

Further, we predicted the number of episodes of liver cirrhosis in the next 20 years by using the Nordpred and the BAPC software packages of the R software. The results found that the number of cirrhosis increased. Based on the Nordpred model analysis, the incidence number of liver cirrhosis has increased from 1,317,848.92 in 1990–1994 to 2,409,435.31 in 2035–2039 (Figure 9(A) and Supplementary Table 3). The BAPC analysis similarly indicated that the incidence number of liver cirrhosis had increased from 1,273,961 in 1990 to 3,438,491 in 2039 (Figure 9(B) and Supplementary Table 3).

Figure 9.

Figure 9.

Statistics and predictions of the number of cases in all age groups: A. Prediction based on Nordpred model; B. Prediction based on BAPC model. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

In all age groups, the analysis found that the number of cases of liver cirrhosis showed a rising trend, and the incidence rate was relatively stable and slightly increased (Figure 10, Supplementary Tables 4 and 5). The same conclusion was obtained using the BAPC model, but the growth was more (Figure 11, Supplementary Tables 6–9). The reason for the larger increase in the BAPC model may be that the Nordpred model analysis uses the average of the 5–year data, which makes the increase less obvious than the BAPC model analysis due to the average.

Figure 10.

Figure 10.

Cirrhosis incidence 1990–2019 and projections for the next 20 years, stratified by gender: A. Number of female cases; B. Female incidence rate; C. Number of male cases; D. Male incidence rate. Prediction of changes over the next 20 years based on the Nordpred model. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

Figure 11.

Figure 11.

Cirrhosis incidence 1990–2019 and projections for the next 20 years, stratified by gender: A. Number of female cases; B. Female incidence rate; C. Number of male cases; D. Male incidence rate. Prediction of changes over the next 20 years based on the BAPC model. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

Due to changes in time and age, we projected ASR changes in the next 20 years based on the analysis of ASR changes in cirrhosis over the past 30 years. Nordpred model analysis showed that ASR in females decreased from 20.86 per 100 in 1990–1994 to 20.4 in 2010–2014 and then continued to increase to 21.38 in 2035–2039 (Figure 12(A) and Supplementary Table 10). However, the ASR for males was 29.81 per 100,000 in 1990–1994, then fluctuated and dropped to 29.5 in 2020–2024 and then rose to 29.62 in 2035–2039 (Figure 12(B) and Supplementary Table 10). The prediction results of the BAPC model showed a similar trend change. The ASR value for females fluctuated from (21.04206 ± 2.96e–07) per 100,000, in 1990 to the lowest level in 2014 (20.29454 ± 2.30e–07), and then gradually increased to (27.38541 ± 7.01e–05) (Figure 12(C) and Supplementary Table 11) in 2039. Similarly, the 1990 ASR value for males was (30.10715 ± 3.47e–07) per 100,000, then fluctuated and reached the lowest (29.24959 ± 2.73e–07) in 2015, and then gradually rose to (40.54755 ± 1.36E–04) (Figure 12(D) and Supplementary Table 11) in 2039.

Figure 12.

Figure 12.

Statistics and predictions of cirrhosis ASR for different genders: A and B are based on the Nordpred model for females and males, respectively; C and D are based on the BAPC model, respectively. ASR, age–standardized rate. Source: Institute for Health Metrics and Evaluation. Used with permission. All rights reserved.

Combined with the above analysis, it is clear that the incidence of liver cirrhosis will continue to rise in the future, and that the risk of developing liver cirrhosis is always much higher in males than in females.

4. Discussion

Our study is the first to report on changing trends in liver cirrhosis at the global, regional, and national levels over 30 years, and predicts changes over the next 20 years. Furthermore, the targeted analysis of the etiology, risk factors, and the impact of HDI and SDI on ASR, could further guide national healthcare policy development and the implementation of related interventions.

Globally, the number of cases of liver cirrhosis has increased by more than seven hundred thousand cases between 1990 and 2019, reaching a staggering more than 2 million cases by 2019, but the ASR has declined. The reason for this contradiction should be attributed to the rapid increase in population size and aging degree [12,13]. Furthermore, we noted significant differences in ASR across regions. In 2019, the ASR in the central Asia area was as high as 59.1 per 100,000, while the lowest Oceania area was only 8.5 (Table 1). This difference is mainly caused by the types of viral infection, alcohol consumption level, social development level, and the abundance of medical resources [4]. The country–level analysis found the most pronounced decline in the incidence of cirrhosis in the Republic of Korea. Between 1990 and 2019, the number of cases of liver cirrhosis decreased by 43.9%, and the ASR decreased by 3.9% annually (Table 1). The reason for this beneficial change should come from the introduction of vaccination in 1983 and the national immunization in 1995, which reduced the prevalence of hepatitis virus and thus caused a significant decrease in the incidence of cirrhosis [14]. Therefore, immunization at the national level is very effective in reducing the disease burden of liver cirrhosis.

The etiology of liver cirrhosis has similarly changed significantly over the last 30 years. In 1990, the main cause of liver cirrhosis was hepatitis B virus infection (24.3%), but by 2019, HCV infection rose to first place (26.9%) (Figure 4). The all–age prevalence of chronic hepatitis B decreased in all WHO regions between 1990 and 2019, from 6.0% in 1990 to 31 to 4.1% in 2019 [15]. This beneficial change was largely attributed to the availability of the hepatitis B vaccine, with its global coverage estimated at 81% by the end of 2013, and with childhood universal vaccination systems established in 183 out of 194 countries [16]. Our finding that East Asia continues to have the highest rate of HBV–related cirrhosis globally is consistent with the study by Lan et al. [17]. This is mainly due to the large number of hepatitis B patients in China, where about 30% of cirrhosis cases in 2019 were HBV–related [18]. As the other virus, which causes the most liver cirrhosis except for hepatitis B virus, the prevalence of HCV remained relatively stable between 1990 and 2019 [8,11,19]. Therefore, the proportion of liver cirrhosis caused by hepatitis C has increased.

Notably, cirrhosis caused by non–alcoholic steatohepatitis (NASH), a type of NAFLD, is on the rise. A recent meta–analysis of population–based studies suggests that the incidence of NASH has increased globally in recent years [20]. According to NHANES data, the prevalence of NASH cirrhosis increased 2.5–fold from 1999–2002 to 2009–2012 [21]. Ye et al. also showed that the death rate of cirrhosis caused by NASH was increasing, and the increase was most obvious in Asia [22]. The burden of cirrhosis due to NASH will grow due to the global increase in metabolic syndrome and obesity and the lack of viable treatments [23,24]. It is particularly alarming that NASH has become one of the leading causes of liver cancer worldwide [25]. Therefore, weight loss to maintain a normal BMI range to reduce the risk of the metabolic syndrome caused by NASH should be actively promoted worldwide [26,27].

Cirrhosis caused by alcohol use still cannot be ignored. According to our analysis, the proportion of alcoholic cirrhosis and its impact on deaths and DALYs were highest in Central and Western Europe (Figures 4 and 6(A)). A previous study based on GBD 2017 similarly supported our conclusions. The study showed that the highest proportion of alcohol–related cirrhosis deaths was in Central Europe (44.0%) and Western Europe (41.7%) [8]. The burden of disease analysis of alcoholic cirrhosis in the study by Zhang et al. showed that the largest increase in age–standardized death rates was observed in the Eastern European region, whereas the decline was observed in the Western European region [28]. In previous studies, alcohol consumption per capita was high in Eastern Europe and the prevalence of harmful alcohol consumption was still increasing in this region [29,30]. Together with our study, we can predict that the proportion of alcohol–related cirrhosis deaths in Eastern Europe will increase significantly in the future. Thus, regions with a high burden of alcohol–related cirrhosis, such as Central and Western Europe, could reduce alcohol consumption through policies such as increasing alcohol taxes, implementing minimum prices, and raising the national legal drinking age [30,31]. However, alcohol use in the Middle East has the lowest DALYs (11.8%) and deaths (10.4%), which is largely related to religious practices in the region [4]. Unsurprisingly, drug use in North America and high–income North America caused the highest DALYs (41.6%) and deaths (39.4%) (Figure 6(B)). Previous studies have shown that drug use is the second largest route of HCV transmission, widely affecting industrialized countries, especially the United States [32]. The rise in HCV infection in recent years the high levels of DALYs and deaths in liver cirrhosis due to drug use are directly related in North America.

Although there are some exceptions, the age–standardized incidence of liver cirrhosis is inversely associated with SDI at the national level. Correspondingly, a previous GBD 2017–based study showed that higher SDI levels also showed lower DALYs and deaths [8]. In general, a higher SDI in a country is associated with higher economic, educational, and healthcare levels [33]. The study by Gorgani et al. also confirmed that the quality–of–care index (Qci) was higher in countries with high SDI [34]. Therefore, well–developed infrastructure, higher education level, and medical quality may be associated with lower ASR of liver cirrhosis in areas with high SDI. Notably in Central Asia and Latin America, the ASR was significantly higher than at baseline and tended to increase (Figure 8). As in the previous analysis in this paper, DALYs and deaths were equally high in alcohol use in these two areas (Figure 6(A)). The study by Manthey et al. also showed a high prevalence of alcohol use disorders in Central Asia [35]. Therefore, reasoned that the abnormal increase in ASR in these two regions should be attributed to alcohol use and that alcoholic cirrhosis due to high alcohol consumption should be the primary cause of the remaining high ASR in both regions [36,37].

Both Nordpred and BAPC models predict a significant increase in the number of cirrhosis cases over the next 20 years (Figures 9–12). This trend may result from the following two reasons, first, the growth and aging of the global population [38]. Second, there is an increased incidence of cirrhosis. As shown in Figure 12, the results predicted by both models indicated that the ASR of liver cirrhosis showed an overall increasing trend in the two decades after 2019. Interestingly, we found that the ASR of liver cirrhosis did not show a consistent upward trend since 1990 but fluctuated downward and then increased. Clearly, the decline in cirrhosis ASR has been due to widespread vaccination, screening, and antiviral treatment, but the increase in injection drug use, alcohol abuse, and metabolic syndrome in recent years has largely offset these benefits and will make the burden of cirrhosis even greater in the future [39].

Analyses for 1990–2019 and projections for the next 20 years both suggest that ASR is significantly higher in males than in females with cirrhosis. This difference stems from higher HBV and HCV infection, alcohol consumption, and drug injection in males [17,40]. Previous studies have shown that females have higher rates of hepatitis B surface antigen clearance and seroconversion, higher rates of hepatitis C virus clearance, and better response to interferon therapy [41–43]. In addition, oestrogen in premenopausal females can inhibit hepatic stellate cell activation and fibrosis, and lower alcohol consumption in females also leads to a significantly lower incidence of alcoholic liver disease than in males [37,44,45]. Thus, the combination of these factors contributes to a much higher global burden of cirrhosis among males than among females.

In recent years, the refugee problem caused by war, poverty, and economic and social reasons has also changed the disease burden of cirrhosis. Globally, refugees mostly come from developing countries in the south and enter advanced economies such as North America and Western Europe [46]. It is estimated that about 10% of the population of the European Region are migrants or refugees [47]. In addition, Italy has about half a million refugees, mainly from Central and East Asia, North Africa, Sub–Saharan Africa, and Eastern Europe [48]. However, these refugees often come from countries that have moderate or high prevalence rates of viral liver disease [49,50]. A survey of 12,880 refugees in Germany showed a significantly higher HCV seroprevalence than the general German population [51]. Coppola et al. screened 882 refugees from Italy and found that the HBV seropositive rate was as high as 8%, which was significantly higher than the level of the Italian native population [52]. Similarly, a recent survey of refugees in Ontario, Canada, found a higher incidence of HBV–related cirrhosis among refugees than among native populations [53]. Therefore, the entry of refugees with high rates of viral hepatitis and the associated development of cirrhosis can greatly challenge the health care system of the host country. Strengthening the education of related protection knowledge, popularizing the detection of hepatitis virus infection, and injecting hepatitis B vaccine are effective methods to reduce the burden of liver cirrhosis in refugees.

In addition, considering that treatment of cirrhosis other than liver transplantation is not very prominent in improving the survival benefit of patients with decompensated cirrhosis [54]. Therefore, more extensive and effective methods should be implemented to prevent the occurrence of liver cirrhosis. The government should further formulate necessary public health policies to intervene in high–burden areas and high–risk populations. Examples include strengthening hepatitis B vaccination and publicizing the dangers of alcohol use and obesity. In addition, screening for transient elastography should be encouraged in patients with metabolic syndrome, chronic alcohol use, and chronic hepatitis for early diagnosis. We should not only focus on developed and developing regions but also provide essential vaccines and medicines to underdeveloped regions. Therefore, cooperation among countries and coordination among international organizations play a crucial role in reducing the global burden of liver cirrhosis.

Although the analysis of GBD in this paper can largely conclude the burden of liver cirrhosis and projections for the future, the text still has several limitations. First, this paper mainly discusses the trend of the incidence of liver cirrhosis, the number of patients with liver cirrhosis, and the forecast value up to 2039. However, the analysis and prediction of DALYs and death trends were not analysed, only the changes in these two indicators caused by different risk factors in 1990 and 2019 were analysed. Further analyses of DALYs and deaths in liver cirrhosis are planned to better describe the disease burden of liver cirrhosis and complement the present study. Second, the accuracy of GBD estimation largely depends on the quality and quantity of the data. As in the analysis of risk factors for cirrhosis, we did not find data on smoking in the database to analyze its effect on cirrhosis. Third, the assessment of exposure risk has a delayed effect. Although we assessed SEV, DALYs, and Deaths attributable to alcohol and drug use, further follow–up is needed to determine whether related exposures contribute to the increased risk of long–term cirrhosis.

5. Conclusions

In conclusion, from 1990 to 2019, the ASR of liver cirrhosis showed a downward trend worldwide, but the number of cases continued to rise. HCV infection has also replaced HBV as the leading cause of cirrhosis. In addition, alcohol consumption as a risk factor for cirrhosis should raise alarm. Finally, our projections suggest that the number and incidence of cirrhosis will continue to increase until 2039. As a result, the global burden of cirrhosis will continue to increase, and countries should adopt broader and more effective approaches to prevent cirrhosis based on its most common causes.

Supplementary Material

Supplemental Material
IANN_A_2328521_SM2269.zip (269.6KB, zip)

Acknowledgements

The authors thank everyone working for this study. We also appreciate the work of the Global Burden of Disease study 2019 collaborators.

Funding Statement

This article is supported by Key Research and Development Program of Shaanxi (Program No. 2021SF–227), the National Natural Science Foundation of China (grant number 31500650), the Key Research & Development Program–Social Development of Shaanxi Province (grant number 2020SF–063) and Natural Science Foundation of Shaanxi Province (2022JCYB–770).

Author contributions

Yikai Wang conceived and designed the study. Yikai Wang analyzed data and wrote the manuscript. Muqi Wang and Chenrui Liu, checked the analysis results. Miao Hao, Wenjun Wang, and Juanjuan Shi helped collect data and references. Yaping Li, Xiaoli Jia, and Xin Zhang checked the article’s format and language. Shuangsuo Dang is responsible for the overall content as a guarantor.

Ethical approval and consent to participate

The institutional review board of the Second Affiliated Hospital of Xi’an Jiaotong University in Shaanxi Province, China, determined that the study did not need approval because it used publicly available data.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data were obtained through an online query tool from the website of IHME (http://ghdx.healthdata.org/), and no permissions were required to access the data.

References

  • 1.Pinzani M, Rosselli M, Zuckermann M.. Liver cirrhosis. Best Pract Res Clin Gastroenterol. 2011;25 (2):1–34. doi: 10.1016/j.bpg.2011.02.009. [DOI] [PubMed] [Google Scholar]
  • 2.Tsochatzis EA, Bosch J, Burroughs AK.. Liver cirrhosis. Lancet. 2014;383 (9930):1749–1761. doi: 10.1016/S0140-6736(14)60121-5. [DOI] [PubMed] [Google Scholar]
  • 3.Schuppan D, Afdhal NH.. Liver cirrhosis. Lancet. 2008;371 (9615):838–851. doi: 10.1016/s0140-6736(08)60383-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mokdad AA, Lopez AD, Shahraz S, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12 (1):145. doi: 10.1186/s12916-014-0145-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Digestive diseases in the United States: epidemiology and Impact . NIDDK; Bethesda, MD: 1994. NIH Publication No. 94–1447. [Google Scholar]
  • 6.National Center for Health Statistics. US Department of Health and Human Services, Centers for Disease Control and Prevention; Hyattsville, MD: 2005. Series 13. [Google Scholar]
  • 7.Li M, Wang ZQ, Zhang L, et al. Burden of cirrhosis and other chronic liver diseases caused by specific etiologies in China, 1990–2016: findings from the global burden of disease study 2016. Biomed Environ Sci. 2020;33 (1):1–10. doi: 10.3967/bes2020.001. [DOI] [PubMed] [Google Scholar]
  • 8.Collaborators, G.B.D.C . The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5 (3):245–266. doi: 10.1016/S2468-1253(19)30349-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396 (10258):1204–1222. doi: 10.1016/S0140-6736(20)30925-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Golabi P, Paik JM, AlQahtani S, et al. Burden of non–alcoholic fatty liver disease in asia, the Middle east and North africa: data from global burden of disease 2009–2019. J Hepatol. 2021;75 (4):795–809. doi: 10.1016/j.jhep.2021.05.022. [DOI] [PubMed] [Google Scholar]
  • 11.Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70 (4):674–683. doi: 10.1016/j.jhep.2018.12.001. [DOI] [PubMed] [Google Scholar]
  • 12.Xiao S, Xie W, Zhang Y, et al. Changing epidemiology of cirrhosis from 2010 to 2019: results from the global burden disease study 2019. Ann Med. 2023;55 (2):2252326. doi: 10.1080/07853890.2023.2252326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Tan D, Chan KE, Wong ZY, et al. Global epidemiology of cirrhosis: changing etiological basis and comparable burden of nonalcoholic steatohepatitis between males and females. Dig Dis. 2023;41 (6):900–912. doi: 10.1159/000533946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yim SY, Kim JH.. The epidemiology of hepatitis B virus infection in korea. Korean J Intern Med. 2019;34 (5):945–953. doi: 10.3904/kjim.2019.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Collaborators, G.B.D.H.B . Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7 (9):796–829. doi: 10.1016/S2468-1253(22)00124-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wiktor SZ. Viral hepatitis. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, Editors. Major infectious diseases. Washington (DC): The International Bank for Reconstruction and Development/The World Bank© 2017 International Bank for Reconstruction and Development/The World Bank., 2017. [Google Scholar]
  • 17.Lan Y, Wang H, Weng H, et al. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2019. Hepatol Commun. 2023;7 (2):e0026–e0026–e0026. doi: 10.1097/hc9.0000000000000026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Huang P, Zhu LG, Zhu YF, et al. Seroepidemiology of hepatitis B virus infection and impact of vaccination. World J Gastroenterol. 2015;21 (25):7842–7850. doi: 10.3748/wjg.v21.i25.7842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ouyang G, Pan G, Guan L, et al. Incidence trends of acute viral hepatitis caused by four viral etiologies between 1990 and 2019 at the global, regional and national levels. Liver Int. 2022;42 (12):2662–2673. doi: 10.1111/liv.15452. [DOI] [PubMed] [Google Scholar]
  • 20.Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta–analysis. Lancet Gastroenterol Hepatol. 2022;7 (9):851–861. doi: 10.1016/s2468-1253(22)00165-0. [DOI] [PubMed] [Google Scholar]
  • 21.Kabbany MN, Conjeevaram Selvakumar PK, Watt K, et al. Prevalence of nonalcoholic Steatohepatitis–Associated cirrhosis in the United States: an analysis of national health and nutrition examination survey data. Am J Gastroenterol. 2017;112 (4):581–587. doi: 10.1038/ajg.2017.5. [DOI] [PubMed] [Google Scholar]
  • 22.Ye F, Zhai M, Long J, et al. The burden of liver cirrhosis in mortality: results from the global burden of disease study. Front Public Health. 2022;10:909455. doi: 10.3389/fpubh.2022.909455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Diehl AM, Day C.. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377 (21):2063–2072. doi: 10.1056/NEJMra1503519. [DOI] [PubMed] [Google Scholar]
  • 24.Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease–Meta–analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64 (1):73–84. doi: 10.1002/hep.28431. [DOI] [PubMed] [Google Scholar]
  • 25.Huang DQ, Singal AG, Kono Y, et al. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022;34 (7):969–977 e2. doi: 10.1016/j.cmet.2022.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lazarus JV, Mark HE, Anstee QM, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19 (1):60–78. doi: 10.1038/s41575-021-00523-4. [DOI] [PubMed] [Google Scholar]
  • 27.Karlsen TH, Sheron N, Zelber–Sagi S, et al. The EASL–Lancet liver commission: protecting the next generation of europeans against liver disease complications and premature mortality. Lancet. 2022;399 (10319):61–116. doi: 10.1016/S0140-6736(21)01701-3. [DOI] [PubMed] [Google Scholar]
  • 28.Zhang X, Zhang X, Liu M, et al. Global, regional, and national burden of cirrhosis and other chronic liver diseases due to alcohol use, 1990–2019: a systematic analysis for the global burden of disease study 2019. BMC Gastroenterol. 2022;22 (1):484. doi: 10.1186/s12876-022-02518-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Shield K, Manthey J, Rylett M, et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. Lancet Public Health. 2020;5 (1):e51–e61. doi: 10.1016/S2468-2667(19)30231-2. [DOI] [PubMed] [Google Scholar]
  • 30.Collaborators GBDA. Population–level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the global burden of disease study 2020. Lancet. 2022;400 (10347):185–235. doi: 10.1016/S0140-6736(22)00847-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Paik J, Henry L, Younossi Y, et al. The global burden of liver cancer (LC) and chronic liver diseases (CLD) is driven by non–alcoholic steatohepatitis (NASH) and alcohol liver disease (ALD). Journal of Hepatology. 2022;77: s 5–S7. doi: 10.1016/s0168-8278(22)00435-4. [DOI] [Google Scholar]
  • 32.Suryaprasad AG, White JZ, Xu F, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Infect Dis. 2014;59 (10):1411–1419. doi: 10.1093/cid/ciu643. [DOI] [PubMed] [Google Scholar]
  • 33.Global Burden of Disease Health Financing Collaborator, N . Past, present, and future of global health financing: a review of development assistance, government, out–of–pocket, and other private spending on health for 195 countries, 1995–2050. Lancet. 2019;393 (10187):2233–2260. doi: 10.1016/S0140-6736(19)30841-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gorgani F, Esfahani Z, Ghamari SH, et al. Global, regional, and national burden and quality of care index of liver cirrhosis by cause from global burden of disease 1990–2019. J Gastroenterol Hepatol. 2023;38 (1):119–128. doi: 10.1111/jgh.16041. [DOI] [PubMed] [Google Scholar]
  • 35.Manthey J, Shield KD, Rylett M, et al. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet. 2019;393 (10190):2493–2502. doi: 10.1016/s0140-6736(18)32744-2. [DOI] [PubMed] [Google Scholar]
  • 36.Liangpunsakul S, Haber P, McCaughan GW.. Alcoholic liver disease in asia, Europe, and North America. Gastroenterology. 2016;150 (8):1786–1797. doi: 10.1053/j.gastro.2016.02.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Griswold MG, Fullman N, Hawley C, et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2018;392 (10152):1015–1035. doi: 10.1016/S0140-6736(18)31310-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Murray CJL, Callender CSKH, Kulikoff XR, et al. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392 (10159):1995–2051. doi: 10.1016/S0140-6736(18)32278-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Moon AM, Singal AG, Tapper EB.. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18 (12):2650–2666. doi: 10.1016/j.cgh.2019.07.060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Zhang T, Xu J, Ye L, et al. Age, gender and geographic differences in global health burden of cirrhosis and liver cancer due to nonalcoholic steatohepatitis. J Cancer. 2021;12 (10):2855–2865. doi: 10.7150/jca.52282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Zacharakis GH, Koskinas J, Kotsiou S, et al. Natural history of chronic HBV infection: a cohort study with up to 12 years follow–up in North Greece (part of the interreg I–II/EC–project). J Med Virol. 2005;77 (2):173–179. doi: 10.1002/jmv.20434. [DOI] [PubMed] [Google Scholar]
  • 42.Di Martino V, Lebray P, Myers RP, et al. Progression of liver fibrosis in women infected with hepatitis C: long–term benefit of estrogen exposure. Hepatology. 2004;40 (6):1426–1433. doi: 10.1002/hep.20463. [DOI] [PubMed] [Google Scholar]
  • 43.Villa E, Karampatou A, Cammà C, et al. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Gastroenterology. 2011;140 (3):818–829.e2. doi: 10.1053/j.gastro.2010.12.027. [DOI] [PubMed] [Google Scholar]
  • 44.Codes L, Asselah T, Cazals–Hatem D, et al. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut. 2007;56 (3):390–395. doi: 10.1136/gut.2006.101931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Yasuda M, Shimizu I, Shiba M, et al. Suppressive effects of estradiol on dimethylnitrosamine–induced fibrosis of the liver in rats. Hepatology. 1999;29 (3):719–727. doi: 10.1002/hep.510290307. [DOI] [PubMed] [Google Scholar]
  • 46.Coppola N, Alessio L, Onorato L, et al. Epidemiology and management of hepatitis C virus infections in immigrant populations. Infect Dis Poverty. 2019;8 (1):17. doi: 10.1186/s40249-019-0528-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.https://www.who.int/health–topics/refugee–and–migrant–health#tab=tab_1.
  • 48.Coppola N, Alessio L, Gualdieri L, et al. Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features. Infect Dis Poverty. 2017;6 (1):33. doi: 10.1186/s40249-016-0228-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sharma S, Carballo M, Feld JJ, et al. Immigration and viral hepatitis. J Hepatol. 2015;63 (2):515–522. doi: 10.1016/j.jhep.2015.04.026. [DOI] [PubMed] [Google Scholar]
  • 50.Pisaturo M, Alessio L, Starace M, et al. Characterization of hepatitis virus co–infections in a cohort of immigrants living in Southern Italy. J Med Virol. 2023;95 (3):e28665. doi: 10.1002/jmv.28665. [DOI] [PubMed] [Google Scholar]
  • 51.Mattlinger C, Thumfart JO, Heinen W[, et al. Hepatitis C virus seroprevalence and dependency on country of origin of refugees in Rhineland–Palatinate, Germany in 2015]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61 (11):1472–1480. doi: 10.1007/s00103-018-2816-x. [DOI] [PubMed] [Google Scholar]
  • 52.Coppola N, Alessio L, Gualdieri L, et al. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in Southern Italy, january 2012 to june 2013. Euro Surveill. 2015;20 (35):30009. doi: 10.2807/1560-7917.ES.2015.20.35.30009. [DOI] [PubMed] [Google Scholar]
  • 53.Sayed N, Selzner N, Djerboua M, et al. Incidence of cirrhosis among recent immigrants and refugees to Ontario, Canada. Am J Gastroenterol. 2023;118 (7):1289–1292. doi: 10.14309/ajg.0000000000002214. [DOI] [PubMed] [Google Scholar]
  • 54.Gluud C. Mortality from cirrhosis: lack of progress over the last 35 years. Gut. 2005;54 (11):1523–1526. doi: 10.1136/gut.2005.072876. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material
IANN_A_2328521_SM2269.zip (269.6KB, zip)

Data Availability Statement

The data were obtained through an online query tool from the website of IHME (http://ghdx.healthdata.org/), and no permissions were required to access the data.


Articles from Annals of Medicine are provided here courtesy of Taylor & Francis

RESOURCES